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IVlore than 400 cancer survivors, 
family, friends, and caregivers gath- 
ered in The Eric P. Newman Education 
Center on the Washington University 
Medical Center campus to celebrate 
life and to share the memories of 
hard-fought battles and sweet 
victories over a dreaded disease. ▼ 
1 Herman Bockstruck, 22-year cancer survivor; 
Carlos Perez, MD, director of the Radiation 
Oncology Center; and William Peck, MD, dean 
of the medical school. 
mmym M 
2 Washington University Chancellor Mark 
Wrighton visited with former patients and 
their guests. 
3 Code Blues provided swinging sounds and a 
feel-good mood. 
4 Radiation Oncology's Perry Cole and Ernes- 
tine Easley welcomed Virgil and Lillian Petty. 
5 Dr. Carlos and Susie Perez with Chester 
Moore (third from left), his family and friends. 
6 Dr. Todd Wasserman, who has been 
organizing Celebration of Life since 1989, and 
ten-year-old Adam Gacioch, the youngest cancer 
survivor attending the event. 
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MALLINCKRODT INSTITUTE OF RADIOLOGY 
AN ATLAS OF DISCOVERY 
Researchers in MIR's molecular radiopharmacology lab 
are investigating why some tumor cells reject certain 
chemotherapeutic agents. Information gained from this 
study could result in improved treatment for patients 
with cancer. 
14 PET: A LOGICAL TOOL 
IN THE FIGHT AGAINST 
BREAST CANCER 
Two significant clinical trials will determine if 
positron emission tomography (PET) is an effective, 
noninvasive method for evaluating lymph-node 
involvement in breast cancer and for identifying 
which estrogen-receptor-positive breast tumors will 
respond to hormonal therapy. 
IN MEMORIAM 
A tribute to Dr. Michel Ter-Pogossian, an innovative 
researcher known as "the father of PET," who devoted 
more than four decades to the improvement of medical 
imaging. 
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ON THE COVER: 
Doctors Farrokh Dehdashti and Barry Siegel are principal investigators in 
studies involving PET, a 25-year-old technology developed at Mallinckrodt 





Marcus Raichle, MD, 
professor of radiology and 
codirector of the Division of 
Radiological Sciences, is one 
of 60 new members of the 
National Academy of Sci- 
ences who were elected in 
recognition of their distin- 
guished and continuing 
achievements in original 
research. Election into the 
Academy is one of the high- 
est honors accorded a United 
States scientist or engineer. 
Established in 1863 by the 
U.S. Congress, the Academy 
acts an an official adviser to 
the federal government in 
matters concerning science 
or technology. 
As far back as 1971, at a 
time when other neuro- 
sciences researchers were 
unfamiliar with cyclotron- 
produced, short-lived 
radionuclides, Raichle pio- 
neered the use of these 
nuclear medicine tools for 
the measurement of cerebral 
blood flow and metabolism. 
For the past decade, his 
research has focused on the 
application of positron emis- 
sion tomography to the study 
of the human brain. That 
research has produced 
groundbreaking discoveries 
in psychiatric disorders and 
in the development of func- 
tional maps of the brain's 
sensory and language infor- 
mation-processing areas. 
Raichle holds joint 
appointments as a professor 
of neurology and of anatomy 
and neurobiology. He is a 
senior fellow with the 
McDonnell Center for Stud- 
ies of Higher Brain Function. 
Raichle joined the Washing- 
ton University Department of 
Neurology in 1971 as a 
research instructor and was 
appointed professor of neu- 
rology in 1978. He was 
named professor of radiology 
in 1979 and professor of 
anatomy and neurobiology in 
1993. Raichle was appointed 
in 1995 as codirector of 
MIR's Division of Radiologi- 
cal Sciences. 
Dennis Choi, MD, PhD, professor and head of the Department of Neurology, congratu- 
lates Marcus Raichle, MD, (right) on his election to the National Academy of Sciences. 





As a member of the 
Friends of Ukrainian Radiol- 
ogy, pediatric radiologist 
Thomas Herman, MD, asso- 
ciate professor of radiology, 
recently traveled to the for- 
mer Soviet state to partici- 
pate in a symposium on 
modern radiological imaging. 
Hundreds of Ukrainian 
physicians and medical stu- 
dents attended the sympo- 
sium where Herman gave 
talks on contemporary cra- 
nial sonography and Doppler 
sonography in infants and on 
contemporary imaging of 
Wilms tumors and other 
malignant renal tumors of 
childhood. 
While in the republic of 
Ukraine, Herman spent two 
days caring for patients at 
the Lviv Regional Children's 
Hospital, where he saw chil- 
dren with illnesses ranging 
from bacterial infections to 
acute leukemia to Burkitt 
lymphoma. Because 
Ukraine lacks even the most 
basic modern medical neces- 
sities, like penicillin, a treat- 
able infection often results in 
a child's death. 
Herman observed that 
the citizens of Lviv, like most 
other people in the regions 
surrounding the site of the 
1986 Chernobyl nuclear acci- 
dent, attribute perceived 
increases in disease to the 
accident. However, based 
on the scientific evidence 
available, it seems much 
more likely that any increase 
in disease is the result of the 
overall poor health of the 
people in that region and the 
primitive quality of the 
Ukrainian medical system. 
"The needs of the 
Ukrainian radiology commu- 
nity are great because sonog- 
raphy and computerized 
tomography have been intro- 
duced very recently to Lviv, 
and magnetic resonance has 
appeared only recently in 
Ukraine," says Herman. 
"Resources that physicians 
in the United States take for 
granted — books, journals, 
equipment — are not easily 
available to Ukrainian 
doctors." 
If you have medical 
items to donate to the Lviv 
Medical School and the 
Ukrainian Association of 
Radiologists, contact Her- 
man at 314-454-6229. 
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[left to right) Dennis Balfe, MD, and Diagnostic Radiology residents Donald Heck, 1996-1997 chief resident; Eric Weidman, 1995- 
■996 chief resident; Farrel VanWagenen, 1995-1996 cochief resident; and Thomas Vaughan, 1996-1997 chief resident, were on 





Research Program provides 
medical students or science 
undergraduates with 
research experiences in one 
of the many branches of 
radiological sciences: con- 
trast agent development, 
digital imaging, diagnostic 
radiology, magnetic reso- 
nance imaging, molecular 
pharmacology, nuclear med- 
icine, positron emission 
tomography, and radiophar- 
maceutical development. 
The program was begun in 
1993, and, according to Pro- 
gram Coordinator Carolyn 
Anderson, PhD, assistant 
professor of radiology, "pro- 
vides an excellent way to 
introduce students to radio- 
logical sciences research, a 
field that they would have 
very little exposure to in tra- 
ditional science undergrad- 
uate or medical school 
programs." 
As part of this year's 
program, six students were 
paired with mentors, who 
either served individually or 
as part of a team, from the 
divisions of Diagnostic 
Radiology, Nuclear Medi- 
cine, and Radiological Sci- 
ences: James Brink, MD; 
Thomas Conturo, MD, PhD; 
Farrokh Dehdashti, MD; Jay 
Heiken, MD; Elizabeth 
McFarland, MD; Peter Shile, 
MD; Celette Skinner, PhD; 
Richard Slone, MD; and Ge 
Wang, PhD. All reported 
that the program was a 
rewarding experience for 
themselves as well as for 
the students. 
Applications for the 
MIR Summer Research Pro- 
gram will be available in 
November, with an applica- 
tion deadline of February. 
Students will be notified of 
their acceptance in March. 
For further information, 
contact Anderson by e-mail 
(andersoncj @mirlink. wustl. 
edu) or call 314-362-8427. 
Gold Medal 
goes to Evens 
Annually, the Associa- 
tion of University Radiolo- 
gists (AUR) presents the 
Gold Medal in recognition 
of outstanding contribu- 
tions to the specialty of 
radiology. Ronald Evens, 
MD, director of Mallinck- 
rodt Institute, was one of 
two honorees to receive the 
1996 award at the AUR 
Annual Meeting on April 20 
in Birmingham, Alabama. 
The first AUR Gold Medal 
was awarded in 1978, with 
Dr. Hugh Wilson, the Insti- 
tute's second director, as 
one of the two recipients. 
Evens, who is celebrat- 
ing his 25th year as director 
of the Institute, is noted for 
his expertise in a variety of 
radiologic technologies and 
is highly regarded in busi- 
ness issues and the socioe- 
conomics of medicine. 
Under his direction, the 
Institute underwent a major 
expansion program and is 
now one of the largest acad- 
emic radiology departments 
nationwide, with responsi- 
bility for more than 500,000 
radiologic examinations per 
year. 
AUR is an international 
organization of physicians 
and scientists with univer- 
sity-granted faculty appoint- 
ments in the fields of 
radiology, radiation oncol- 
ogy, or nuclear medicine. 
Established in 1953, the 
AUR is the largest society of 
university radiologists in the 
world and is dedicated to 
the promotion of excellence 
in laboratory and clinical 
investigation, teaching, and 
clinical practice. 






Claire Anderson, MD, 
was one of seven award 
recipients honored by the 
Alumni Association at Wash- 
ington University School of 
Medicine's (WUSM) Reunion 
'96 banquet. The award rec- 
ognized outstanding contri- 
butions to the field of 
medicine and to WUSM. 
Anderson, a 1971 medical 
school alumna, joined the 
MIR faculty in 1974. A pro- 
fessor of radiology in the 
chest radiology section, 
Anderson focuses her work 
on clinical diagnostic radiol- 
ogy and is currently involved 
in chest radiology for a large 





At the urging of Perry 
Grigsby, MD, professor of 
radiology in MIR's Radiation 
Oncology Center, the 
National Institutes of Health 
convened a consensus panel 
in April to study the cause, 
prevention, and treatment of 
cervical cancer, one of the 
most prevalent tumors in 
women. The 13-member 
panel found that wider use 
of the Pap test, a diagnostic 
procedure for detecting cer- 
vical cancer, could prevent 
nearly all of the 15,000 new 
cases of this disease that 
occur each year in the 
United States. 
According to Grigsby, 
"One of the most significant 
findings of the panel is the 
importance of routine Pap 
tests. If every woman 
received the Pap test, it 
would dramatically reduce 
the prevalence of this dis- 
ease." Further research is 
needed to establish methods 
for reaching women who are 
most at risk because they fail 
to have the annual test — 
the uninsured, women over 
65, ethnic minorities, and 
rural and poor women. 
Because of a clear link 
between human papilloma- 
virus (HPV) infection and 
cervical cancer, the panel 
stressed the importance of 
HPV vaccine research and of 
educating women about HPV 
prevention. Although most 
women infected with the 
sexually transmitted HPV 
never experience serious 
health problems, scientific 
research has shown that a 
small percentage of women 
with HPV eventually devel- 
ops invasive cancer. 
The consensus panel 
agreed on a protocol for 
treating cervical cancer: 
Hysterectomy or radiation 
therapy is recommended for 
early-stage cancers. In more 
advanced tumors, radiation 
therapy is the treatment of 
choice. Chemotherapy is 
also being evaluated as a 
treatment option. 
RADIOLOGY 
Diagnosis • Treatment • Research 
1895-1995 
PRACTICAL ISSUES IN 
LEADING-EDGE RADIOLOGY 
OCTOBER 11-13.1996 
I Symposium Sponsored by 
The Mallinckrodt Institute of Radiology 
ami the Washington I diversity 
Off ice of Continuing Medical Education 
Approved for 22.5 Hours of Category 1 CME Credit 
Coll Linda Macker at 314-362-2916 
for more information. 





Now in its 28th year, the 
Wilson Award honors annu- 
ally a Washington University 
graduating medical student 
who makes meritorious con- 
tributions to the Department 
of Radiology. The award is a 
tribute to Doctor Hugh Wil- 
on, the second director of 
e Institute, who advocated 
e advancement of 
education. 
John Lim, the 1995-1996 
recipient, worked in both 
research and clinical capaci- 
ties in abdominal radiology 
under the mentorship of 
James Brink, MD, associate 
professor of radiology and 
codirector of computed body 
omography (CT). Lim first 
egan working in abdominal 
adiology during the summer 
etween his first and second 
years of medical school as a 
participant in the research 
elective program. He devel- 
oped image-processing tech- 
niques to assess the accuracy 
of spiral CT depiction of 
renal arterial stenoses and 
also worked closely with Ge 
Wang, PhD, assistant profes- 
sor of radiology and the CT 
physicist, to implement novel 
signal-processing techniques. 
"John is highly moti- 
vated, innovative, and metic- 
ulous in the execution of his 
research. His diligence 
resulted in the rapid publica- 
tion of a manuscript in the 
journal Radiology," says 
Brink. "John has an excel- 
lent fund of medical knowl- 
edge as well as a keen 
interest in the problems 
faced by diagnostic 
radiologists." 






has entered into a three-year 
collaboration with Siemens 
Nuclear Medicine Group to 
market a new generation of 
iterative reconstruction 
algorithms developed by 
researchers in MIR's Divi- 
sion of Nuclear Medicine. 
Although coprincipal inves- 
tigators Jerold Wallis, MD, 
and Tom Miller, MD, PhD, 
are only a year into their col- 
laboration with Siemens, the 
two have been researching 
the new-generation algo- 
rithms for more than 10 
years. The research uses 
nuclear medicine images 
obtained as part of a single- 
photon emission computed 
tomography (SPECT) study 
and processes the images 
with a computer program. 
This program utilizes the 
newly developed algorithms 
to reconstruct a more accu- 
rate image than that avail- 
able from current clinical 
software. 
"The innovations we've 
developed at the Mallinck- 
rodt Institute are designed 
to dramatically speed up the 
processor-intensive portions 
of the algorithm such as re- 
projection and resolution 
recovery. Faster conver- 
gence is a principal advan- 
tage of our algorithm," says 
Wallis. 
"Bringing improved 
quantitative accuracy with 
clinically acceptable recon- 
struction times to the clini- 
cal environment is the goal 
of the project. The first gen- 
eration of two-dimensional 
algorithms with collimator- 
specific resolution recovery 
will be the platform for 
launching incremental 
improvements such as scat- 
ter correction and three- 
dimensional reconstruction," 
adds Miller. 
Until recently, it was 
not feasible to use the new 
algorithms clinically because 
so much time was needed in 
the image-reconstruction 
process. Through their 
research, Wallis and Miller, 
aided by summer student 
Michelle Miller and Post- 
doctoral Fellow Guang-ming 
Dai, PhD, hope to complete 
the computer processing of 
a typical patient within 20 
minutes, thus making the 
algorithm suitable for clini- 
cal use. Clinical trials are 
planned by the end of the 
summer. 
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DISCOVERY 
L^J     David Piwnica-Worms, MD, PhD, and his 
team of scientists at Mallinckrodt Institute of 
Radiology (MIR) stand at a figurative Arc de 
Triomphe, with innumerable research avenues 
radiating in every direction. Some of these 
roads provide the team with unforeseen 
opportunities, others allow the export and 
growth of their own discoveries. One thing is 
true: The research itself is a virtual metropolis 
of application and innovation and holds great 
promise for improved patient care. 
by Joanna B. Downer 
Chemist Vijay Shormo, PhD, (left) and 
David Piwnica-Worms, MD, PhD, head of 
MIR's molecular radiopharmacology lab. 
Piwnica-Worms, an associate 
professor of radiology at MIR 
and an associate professor of mole- 
cular biology and pharmacology at 
Washington University, focuses his 
research on multidrug resistance 
(MDR) in cancer and, more 
recently, in infectious disease. 
MDR is characterized by a tumor 
cell that, after exposure to just a 
single chemotherapeutic agent, 
becomes nonresponsive to a whole 
host of other agents, which may 
only slightly resemble each other 
chemically. One manifestation of 
MDR tumors is the cell surface 
presence of a large molecule, P-gly- 
coprotein (Pgp), which spans the 
cell membrane. Pgp is also present 
in some normal tissues, such as the 
liver and kidneys. In MDR, once 
Pgp is activated by an MDR-induc- 
ing agent, the protein acts as a one- 
way highway, rapidly transporting 
the administered drug and any 
"member" drugs out of the cell, 
explains Piwnica-Worms. 
Multidrug resistance has a seri- 
ous effect on cancer treatment 
because many commonly used 
chemotherapeutic agents induce 
resistance in predisposed cells, 
resulting in failed therapy and 
fewer treatment options for the 
patient. Knowledge of a patient's 
MDR status prior to initialization of 
treatment could result in a more 
effective first line of therapy, and 
this is where Piwnica-Worms and 




cell outtake samples. 
Piwnica-Worms arrived at the 
study of MDR and Pgp almost 
by chance. While on staff at Har- 
vard Medical School's Brigham 
and Women's Hospital, he began 
examining the cellular uptake 
mechanism of technetium-99m- 
SESTAMIBI (99mTc-SESTAMIBI), 
a compound used in cardiac perfu- 
sion imaging to measure and verify 
blood flow to the heart muscle 
using single photon emission com- 
puted tomography (SPECT). 
Radioactive 99mTc decays by emit- 
ting a packet of energy, called a 
photon, which is detected outside 
of the body by a SPECT scanner. 
A computer-generated image of the 
decay process permits visualization 
of the localization of the radiophar- 
maceutical within the body, with- 
out the physician ever having to 
pick up a scalpel. Such noninva- 
sive imaging techniques are 
extremely beneficial in diagnosis 
and evaluation of cancer and other 
diseases. 
MALLINCKRODT INSTITUTE OF RADIOLOGY 
During this time, Piwnica- 
Worms found that 99mTC-SES- 
TAMIBI is taken up by the cells, 
then concentrated and retained in 
tiny compartments within the cell 
called mitochondria. The chemical 
nature of Tc-SESTAMIBI is 
lipophilic and cationic. Its 
lipophilic, or fat loving, nature per- 
mits the compound to flow freely 
across the cellular membrane and 
into the cell. Tc-SESTAMIBI's 
cationic, or positive, charge then 
allows it to be transported into the 
negatively charged interior of the 
mitochondria. This process hap- 
pens repeatedly, resulting in the 
accumulation of a high level of the 
radiopharmaceutical within the 
mitochondria, where the compound 
essentially becomes stuck. 
In other tissues, such as the 
liver and kidneys, Piwnica-Worms 
found that the 99mTc-SESTAMIBI 
was not retained as it was in the 
heart. Instead it was extruded from 
the cells at a very high rate, faster 
than it could travel into the mito- 
chondria. The reason for this 
exporting of the radiopharmaceuti- 
cal led Piwnica-Worms down the 
road to multidrug-resistance 
imaging. 
Aware of Pgp presence in the 
liver and kidneys, Piwnica-Worms 
hypothesized that Pgp was respon- 
sible for the rapid clearance of 
99mTC-SESTAMIBI from these 
organs. Since this first discovery 
that 99mTc_SESTAMIBI retention is 
inversely related to the presence of 
Pgp, the research team has under- 
taken exhaustive biochemical stud- 
ies to prove without a doubt that 
Pgp is responsible for the differ- 
ences in tissue uptake. 
Piwnica-Worms and his team 
came to MIR in August of 1994, 
continuing their in-depth study of 
the mechanism and behavior of Pgp 
and 99mTc_sESTAMIBI. Biochemist 
Carolyn Crankshaw, MS, examined 
the relationship between uptake of 
99mTc-SESTAMIBI and tumor-cell 
lines with different levels of Pgp. 
Vallabhaneni Rao, PhD, a bio- 
chemist, has been instrumental in 
verifying the role of Pgp through 
the use of human DNA transferred 
into baculovirus, a DNA virus that 
is made to infect insect cells in the 
laboratory. It is then amplified for 
proof of the connection between 
the human gene, MDR1 (which 
codes for the production of Pgp), 
Pgp itself, and differences in99mTc- 
SESTAMIBI uptake. As a result of 
their painstaking work, 99mTc-SES- 
TAMIBI is moving beyond heart 
imaging. 
Gary Luker, MD, a research fel- 
low in Piwnica-Worms' laboratory, 
has collaborated with Doctors 
Nancy Bartlett and Paula Fracasso 
of the Division of Hematology- 
Oncology and with Doctors Barry 
Siegel and Henry Royal of the Divi- 
sion of Nuclear Medicine on a pilot 
clinical trial using 99mTC-SES- 
TAMIBI. During the study, baseline 
images were obtained that showed 
the expected rapid clearance of 
99mTc-SESTAMIBI from the liver 
and kidney. Administration of a 
high potency Pgp reversal agent 
(called PSC 833 and provided by 
Sandoz Pharmaceuticals) and sub- 
sequent reinjection of 99mTc-SES- 
TAMIBI resulted in the 
accumulation and prolonged reten- 
tion of the imaging agent in those 
tissues, as if Pgp were no longer 
functioning. This is the same result 
we hope to find in tumors, says 
Piwnica-Worms. A multicenter 
Phase lb clinical trial using a differ- 
ent modulator is about to begin, he 
adds. 
AN ATLAS OI 
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This pilot study verified that 
99mTc-SESTAMIBI can distinguish 
between Pgp expressing (multidrug 
resistant) and non-Pgp expressing 
(drug sensitive) tissue. In addition, 
it aided Sandoz in validating PSC 
833 as a useful modulator, a com- 
pound which blocks the Pgp route 
out of the cell and allows retention 
of the normally Pgp-affected drugs 
(99mTc-SESTAMIBI in this case) 
within their intracellular targets. 
It is this kind of two-way street 
between clinical and scientific 
research that is typical of Piwnica- 
Worms' collaborations, as well as 
the nature of the project itself. 
Modulators come in from the clini- 
cal side and rendezvous with 
Piwnica-Worms' well-characterized 
Pgp imaging agent, resulting in the 
validation of both the modulator 
and the radiotracer used to create 
the image. Although many modula- 
tors are in clinical trials, no com- 
pound is in standard practice. 
99mTc-SESTAMIBI is an excellent 
way to noninvasively measure the 
efficacy of the modulators in clini- 
cal trials. 
As a result of the promising 
work with 99mTc_SESTAMIBI, 
Piwnica-Worms has obtained a 
grant from Mallinckrodt Medical 
Inc. to evaluate a series of 99mTc 
compounds known as Q com- 
plexes, which were initially devel- 
oped as cardiac agents. In this 
Knowledge of a 
patient's MDR status 
prior to initializa- 
tion of treatment 
could result in a 
more effective first 
line of therapy. 
collaboration, Piwnica-Worms 
salutes the openness of his collabo- 
rators Doctors Dan Burleigh, Mary 
Marmion, and Karen Deutsch, and 
Mallinckrodt Medical as a whole. 
"This has been an excellent two- 
way academic and industrial rela- 
tionship and is a testimonial to 
their willingness to share and build 
on important data and informa- 
tion," commends Piwnica-Worms. 
Biochemist Vailabhaneni Rao evaluates a Western 
blot of the molecule P-glycoprotein in cancer cells. 
10 
MALLINCKRODT INSTITUTE OFRADIOLOGi 
With assistance by Research 
Technologist Julie Dahlheimer, 
approximately 40 of these Q com- 
plexes have been tested for Pgp 
activity by the techniques devel- 
oped by Crankshaw, Rao, and 
Luker. Three or four of these com- 
pounds exceed 99n»Tc-SESTAMIBI's 
Pgp distinction characteristics in 
cell models. Additional studies are 
now underway to further evaluate 
the most promising candidates for 
MDR Pgp imaging. If the project 
continues to move forward, pilot 
evaluation in patients could begin 
within a year, says Piwnica-Worms. 
Having migrated to the realm of 
discovery and development of 
new radiopharmaceutical imaging 
agents for Pgp, Piwnica-Worms and 
his coworkers began building a 
path to synthesize and to evaluate 
a series of new radiotracers. 
Chemist Vijay Sharma, PhD, is 
responsible for synthesizing this 
new generation of complexes, 
known as N402 compounds. 
Unlike SESTAMIBI, these com- 
pounds possess a broad flexibility 
to incorporate a variety of metals 
besides 99mTc, which opens roads 
to a number of other uses. 
Incorporation of gallium-68, a 
positron-emitting metal, into these 
compounds will permit the use of 
positron emission tomography 
(PET) for visualizion of the MDR 
tumors. PET offers the opportu- 
nity for quantitative functional 
imaging of biological processes, 
which would increase knowledge 
of the circumstances responsible 
for induction of MDR activity by 
chemotherapeutics and subse- 
quent reversal by modulators — 
an area little understood. This 
research is in collaboration with 
Doctors Michael Welch, Laura 
Bass, and David Reichert of MIR's 
Division of Radiological Sciences. 
Beyond diagnostic imaging, 
use of iron (Fe) as the metal in 
these N402 complexes may lead to 
their use as thera- 
peutic agents for 
MDR. It may be pos- 
sible to modify the 
functional groups on 
the basic N402 struc- 
ture in a way that 
would permit the Fe- 
N402 complex to 
block the Pgp exit 
route, resulting in a 
reversal of the MDR 
activity, says 
Piwnica-Worms. 
In fact, Piwnica- 
Worms' ongoing collaboration with 
Doctor Daniel Goldberg of the 
Department of Molecular Microbi- 
ology resulted in a study of the 
therapeutic effect of these iron 
compounds in drug-resistant 
malaria, an infectious disease 
whose MDR activity may be due to 
a Pgp-related protein. One of the 
fortunate characteristics of all of 
these Pgp agents is that after prov- 
ing their transport connection to 
Pgp, they can be used to study 
MDR itself, both in cancer and in 
infectious disease. 
"We have the pleasure of 
working on both sides of the inter- 
face between chemistry and cell 
biology. We can develop and vali- 
date novel agents and then turn 
them around to probe biological 
transport function," explains 
Piwnica-Worms. 
AN ATLAS OI 
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These MDR Pgp imaging agents 
will be of great use to both nuclear 
medicine physicians and their 
patients. Groups around the world 
have begun to realize the advan- 
tages of identifying MDR status 
early using the available 99mTc-SES- 
TAMIBI. One of the major benefits 
of MDR Pgp imaging agents may be 
improved estimation of prognosis 
and risk at initial presentation or 




 everal studies indicate that if 
Hhe patient's tissues contain 
Pgp, there is a high correlation with 
poor outcome and early treatment 
failure. Conversely, when Pgp is 
not present in the tissue, the 
patients have better outcomes and 
longer remissions. This has been 
shown for a wide variety of cancer 
types," explains Piwnica-Worms. 
Knowledge of MDR status 
would affect choice of therapy as 
well. If MDR were present, selec- 
tion of chemotherapeutic agents 
known to be affected by Pgp would 
be curtailed, since failure of such 
drugs would be imminent without a 
modulator. If no modulator was 
available, alternative agents that 
are not transported by Pgp would 
be used from the beginning of ther- 
apy. "It would be quite desirable if 
we can increase the probability 
that the chemotherapy chosen for 
the patient will be successful," 
Piwnica-Worms emphasizes. 
One of the major 
benefits of MDR Pgp 
imaging agents may 
be improved estima- 
tion of prognosis and 
risk at initial presen- 
tation or recurrence 
of disease. 
Ron Dolin, an undergraduate student 
at Washington University, assists Rao 
in verifying the presence of Pgp tumor 
cells. 
I 
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In addition, any of these imag- 
ing agents — 99mTc-SESTAMIBI, 
the Q complexes, or the N402 com- 
plexes — could be used to moni- 
tor the effectiveness of modulators 
administered in an attempt to 
reverse the MDR activity of the 
tumor. During chemotherapy treat- 
ment the modulators close the Pgp 
export path, allowing the 
chemotherapy drug to reach its cel- 
lular destination. The imaging 
agent essentially tracks the 
chemotherapeutic drug, so that 
retention of radioactivity in the 
tumor verifies the efficacy of the 
modulator, explains Piwnica- 
Worms. 
The broad distribution of MDR 
in tumors of various types, as 
well as in infectious disease, pro- 
vides a significant population of 
patients who would benefit from 
development of both Pgp imaging 
agents and modulators. Among its 
many applications, Piwnica-Worms' 
work in developing and testing 
imaging agents improves the ability 
to evaluate modulators in patients. 
The diverse nature of Piwnica- 
Worms' research is supported by his 
presence here at MIR and Washing- 
ton University. "The facilities, the 
equipment, the collaborative rela- 
tionships we've been able to 
develop at Washington University 
have really been a major step for- 
ward for the breadth and quality of 
our research program. A lot of the 
things we've been able to do have 
been a product of the multifaceted 
environment here," says Piwnica- 
Worms. 
In Piwnica-Worms' research, 
the roads of biology, chemistry, and 
clinical and molecular medicine 
intersect. Because of Piwnica- 
Worms' philosophy of rigorous and 
extensive characterization and veri- 
fication at each step along the way, 
from drug development and synthe- 
sis to screening in cells to evalua- 
tion in patients, the road to MDR 
Pgp imaging will be well-traveled 
by the time he is through. EH 
Editor's note: Joanna Downer is a 
chemistry graduate student conduct- 
ing research in MIR's Division of 
Radiological Sciences. 
Research Technologist Julie Dahlheimer checks tissue 
cultures of cancer cells that contain different levels of 
the multidrug resistance molecule Pgp. 
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woman with a suspicious lump in her breast has to hold her breath tv ice.   ♦ 
twice 
WOMAN WITH A SUSPICIOUS LUMP IN HER BREAST HAS TO HOLD HER 
BREATH TWICE. FIRST, SHE MUST UNDERGO A SURGICAL BIOPSY TO SEE 
WHETHER THE LUMP IS MALIGNANT. AND AFTER THE CANCER IS DIAGNOSED, 
SHE AGONIZES WHILE SHE AWAITS THE RESULTS OF A SECOND SURGICAL PROCE- 
DURE:    A LYMPH-NODE DISSECTION THAT WILL SHOW WHETHER OR NOT THE 
CANCER HAS SPREAD AND HOW MANY NODES ARE AFFECTED. PET 
THESE FINDINGS ARE CRITICALLY IMPORTANT TO HER FUTURE. IF HER 
AXILLARY LYMPH NODES ARE FREE OF CANCER, SHE CAN EXPECT A 10-YEAR 
SURVIVAL RATE OF ABOUT 70 PERCENT; IF CANCER IS PRESENT, THE SURVIVAL 
RATE DROPS TO 30 PERCENT. THE NUMBER OF CANCEROUS NODES IS ALSO 
CRUCIAL, SINCE PATIENTS WITH FOUR OR MORE POSITIVE NODES HAVE A MUCH 
POORER PROGNOSIS THAN PATIENTS WITH FEWER AFFECTED NODES. 
A NEW STUDY AT MALLINCKRODT INSTITUTE OF RADIOLOGY AND TWO 
OTHER CLINICAL SITES WILL SOON BE TESTING WHETHER OR NOT THERE IS AN 
ACCURATE, ECONOMICAL, AND NONINVASIVE WAY TO EVALUATE LYMPH-NODE 
METASTASIS USING POSITRON EMISSION TOMOGRAPHY (PET). THE MULTICEN- 
TER STUDY, SUPPORTED BY A $2.8 MILLION GRANT, IS THE FIRST OF ITS KIND 
FUNDED BY THE NATIONAL CANCER INSTITUTE (NCI) FOR THE EVALUATION OF 
THE EFFECTIVENESS OF PET SCANS IN CANCER DIAGNOSIS,    by Candace O'Connor 
PET: A Logical Tool in the Fight Against Breast Cancer 
women will benefit 
Barry Siegel, MD, director of the Division of Nuclear Medicine and princi- 
pal investigator for the St. Louis site, says the outcome of this study 
could have great significance for women with breast cancer. Right now, 
surgery is the only option for evaluating lymph-node involvement. But 
surgery is expensive and uncomfortable, and it also entails some risks, such 
as infections and long-term swelling. 
"Avoiding the expense and discomfort of axillary dissection is an impor- 
tant goal, and PET seems a logical tool for achieving that goal," he says. 
"We're very glad we have the opportunity to evaluate PET's effectiveness in 
this study." 
Along with the lymph-node study, a second 
breast-cancer initiative — also funded by the NCI — 
is underway in the Division of Nuclear Medicine, 
with Farrokh Dehdashti, MD, assistant professor of 
radiology, as the principal investigator. This study, 
which focuses on patients with advanced breast 
cancer with estrogen-receptor-positive tumors, will 
try to predict more accurately which women will 
benefit from hormonal therapy. 
Both studies rely on PET, a noninvasive, imag- 
ing technique developed in the early 1970s by a 
team of Mallinckrodt Institute researchers led by 
the late Dr. Michel Ter-Pogossian. PET provides 
vivid functional images of various organ systems. In 
earlier studies, it has proven to be a sensitive tool 
for distinguishing benign tissue from malignant tis- 
sue and for detecting the spread of cancerous 
tumors. 
Doctors Siegel and Dehdashti examine PET images of 
breast cancer with Duffy Cutler, PhD, a nuclear 
medicine physicist. MIR; 
PET: A Logical Tool 
researchers began planning the lymph-node study nearly five 
tyears. ago, when the U.S. Army announced a new funding pro- 
gram for breast-cancer research. But their first application for funding was 
not successful. When a second Army initiative was announced, Siegel 
joined forces with MIR alumni Edward Coleman, MD, of the Duke Univer- 
sity Medical Center and Richard Wahl, MD, of the University of Michigan 
Medical Center, and resubmitted the proposal. Although the study received 
a highly favorable review, it was once again not funded. 
The three institutions rewrote the grant and submitted it to the NCI with 
Wahl as the overall principal investigator. Two institutions were added to 
the study: the American College of Radiology Clinical Trials Division for 
data management and the Brown University Medical School for help with 
statistical analysis. Last September, the grant was funded; the MIR group's 
portion of the funding is a total of $620,000. Since then, says Siegel, the 
investigators have spent several months finalizing the protocol, preparing 
forms for data gathering, and working out electronic data submission 
issues. Patient recruitment began in July. 
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"We're looking for women with primary breast cancer, who have not 
yet had an axillary dissection but are scheduled for one," says Siegel. "They 
should not have had any therapy — chemotherapy, hormonal therapy, or 
radiation — prior to the axillary dissection." 
A designated surgeon at each study site will refer patients to the 
researchers and serve as a contact for other surgeons who might also be a 
source of patients. Diane Radford, MD, is the surgical contact for the MIR 
group; other members of the team include Doctors Dehdashti and Peter 
Humphrey of the Department of Pathology, a research coordinator, a physi- 
cist, and several technologists. The three sites hope to scan 414 women 
(138 women at each center) over a 30-month period. 
Women recruited for the study will be imaged with PET after receiving 
an injection of F-18 fluorodeoxyglucose (FDG), a radioactive form of sugar 
that is taken up more avidly, and retained longer, by malignant tissues than 
by normal tissues. Earlier studies have reported preliminary success using 
PET and FDG to detect cancer in the axillary nodes of small numbers of 
patients with newly diagnosed breast cancer. 
This new, larger-scale study will compare PET results with the out- 
come of the surgical biopsies, which the women will undergo soon after- 
wards. "Our first goal is to determine the sensitivity and specificity of PET 
in detecting axillary nodal metastasis." says Siegel. "The second goal is to 
see whether or not PET-derived estimates of the extent of metastatic dis- 
ease in the axillary nodes and also in the internal mammary nodes provide 
prognostic information that we couldn't obtain with standard, invasive stag- 
ing methods." 
In a study variation, some 45 patients with large tumors, who will 
receive chemotherapy before their axillary dissections, will also have PET 
scans prior to their treatment and biopsies. "We decided that although we 
wouldn't be able to use these patients to assess how reliable PET is in 
detecting the disease, because the pathology will be changed by the inter- 
vening chemotherapy, we do need to find out if PET is providing reliable 
prognostic information in these patients with more advanced tumors," says 
Siegel. 
To gather prognostic information, researchers plan to follow up with all 
patients over the five-year life of the study to look for any signs of 
recurrence. The referring surgeons will not know any of the results, unless 
PET turns up a life-threatening condition such as a metastasis that has pro- 
gressed beyond the lymph nodes but is unsuspected clinically. 
If this study proves successful, the researchers may next apply for 
funds to evaluate the use of gamma cameras, which are more widely avail- 
able than PET scanners, in assessing nodal metastasis. Meanwhile, says 
Siegel, "for an investigator-initiated grant, this was an unusually large fund- 
ing. We're proud of that. Now we've got to make it the best possible study 
to prove that the confidence placed in us was justified." 
"AVOIDING THE EXPENSE AND 
DISCOMFORT OF AXILLARY DISSEC- 
TION IS AN IMPORTANT GOAL, 
AND PET SEEMS A LOGICAL TOOL 
FOR ACHIEVING THAT GOAL." 
— BARRY SIEGEL, MD 
the sensitivity of PET 
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better quality of life 
"TWO-THIRDS OF PATIENTS WITH 
BREAST CANCER HAVE EXPOSI- 
TIVE TUMORS, BUT ONLY FIFTY 
OR SIXTY PERCENT WILL RESPOND 
TO  HORMONAL  THERAPY." 
— FARROKH DEHDASHTI, MD 
As the lymph-node project gets underway, the study directed by 
Dehdashti, in collaboration with Siegel; Joanne Mortimer, MD, of the 
Division of Hematology/Oncology; and a group of referring clinicians, is 
also just beginning. This research, supported by a four-year, $1.7 million 
NIH grant, will involve 60 women, all of whom have locally advanced 
tumors that have proven through in vitro analysis to be estrogen-receptor 
(ER) positive. Estrogen, a naturally occurring hormone, is strongly sus- 
pected of being a cause for the growth of cancerous cells in the breast. 
"Two-thirds of breast-cancer patients have ER-positive 
tumors," says Dehdashti. "But only fifty or sixty percent will 
respond to hormonal therapy. Nobody knows why. So we 
are trying to find out if our imaging compound, which shows 
the functional status of these receptors, can better identify 
those patients who would respond to hormonal therapy." 
In the study, patients will be injected with both FDG (the 
radioactive form of sugar used in Siegel's study) and F-18 flu- 
oroestradiol (FES), a radioactive form of a natural estrogen. 
Then the patients will be imaged with PET before and after 
^ the start of tamoxifen therapy, an anti-estrogen drug. The 
•^M hypothesis is that the tamoxifen will initially have an agonis- 
tic effect, causing an increase in the FDG uptake in the tumor 
and making it appear that the tumor is getting worse. But if 
the FES uptake goes down at the same time, the tamoxifen 
may be blocking the uptake in the tumor — when in actuality the tumor is 
getting better. If the FDG uptake increases and the FES uptake either does 
not change or decreases only minimally, the tamoxifen may not be working 
and the disease may be progressing. 
Being able to tell early on whether or not hormonal therapy is working 
will also benefit a small percentage of patients who experience a clinical 
problem called the "flare reaction." Typically, a week or two after the start 
of treatment, the patient with flare reaction has an increase in pain or 
swelling of the tumor. Clinically, it may be difficult to distinguish a flare 
reaction from disease progression. Therefore, the physician may decide 
the tamoxifen is not working and then starts the patient on chemotherapy. 
But, in fact, the agonistic effect is transiently causing the tumor to grow 
until the antagonistic effect kicks in, and the patient begins to improve. 
"If we prove our hypothesis, we will be providing unique information 
about therapy," says Dehdashti. "Hormonal therapy is less toxic than 
chemotherapy, which can make patients very ill. If the clinician prema- 
turely stops the hormonal therapy, this action actually takes away the 
patient's opportunity for a better quality of life." EM 
PET: A Logical Tool 
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11 Mallinckrodt Institute 
'acuity and staff names in 
his section are highlighted 
,n boldface type. 
PROMOTIONS 
Carlos Aquino-Aponte, 
MD, instructor in radiology, 
I was promoted to assistant 
rofessor of radiology, Divi- 
sion of Diagnostic 
Radiology. 
lliam Dawson, MD, 
sistant professor of radiol- 
ogy, was promoted to associ- 
ate professor of radiology, 
ivision of Diagnostic 
adiology. 
lomas Herman, MD, 
ssistant professor of radiol- 
ogy, was promoted to associ- 
ate professor of radiology, 
Division of Diagnostic 
Radiology. 
ssen Kirov, PhD, research 
associate, was promoted to 
instructor in radiology, Radi- 
ation Oncology Center. 
William Mehard, MD, 
instructor in radiology, was 
promoted to assistant pro- 
fessor of radiology, Division 
of Diagnostic Radiology. 
Linda Proctor, MD, 
instructor in radiology, was 
promoted to assistant pro- 
fessor of radiology, Division 
of Diagnostic Radiology. 
David Reichert, PhD, 
research associate, was pro- 
moted to research instructor 
in radiology, Division of 
Radiological Sciences. 
Dmitriy Yablonskiy, PhD, 
research associate, was pro- 
moted to research instructor 
in radiology, Division of 
Radiological Sciences. 
JOINT APPOINTMENTS 
Thomas Conturo, MD, 
PhD, assistant professor of 
radiology, received a joint 
appointment as an adjunct 




Mary Alderman, MD, 
instructor in radiology, is a 
fellow in vascular and inter- 
ventional radiology. She 
completed four years of 
training in diagnostic radiol- 
ogy at Mallinckrodt Institute 
of Radiology and is a mem- 
ber of Alpha Omega Alpha. 
Robert Buse, MD, instruc- 
tor in radiology, is a fellow in 
neuroradiology. He received 
an undergraduate degree 
from Xavier University, 
Cincinnati, Ohio, and a med- 
ical degree from the Univer- 
sity of Cincinnati. Buse 
completed a four-year resi- 
dency in diagnostic radiol- 
ogy at Vanderbilt University, 
Nashville, Tennessee, and is 
a member of Alpha Omega 
Alpha. 
Serge Djukic, MD, instruc- 
tor in radiology, is a fellow in 
neuroradiology. He received 
an undergraduate degree 
from Peta Beogradska Gim- 
nazija and a medical degree 
from the University of Bel- 
grade, Yugoslavia. Djukic 
completed four years of 
training in diagnostic radiol- 
ogy at the University of Cali- 
fornia, San Diego. 
James Duncan, MD, PhD, 
assistant professor of radiol- 
ogy and of cell biology and 
physiology, is a fellow in vas- 
cular and interventional radi- 
ology. He was a radiology 
resident (cochief resident, 
1993-1994) and research 
instructor at Mallinckrodt 
Institue of Radiology. Dun- 
can is a member of Alpha 
Omega Alpha. 
Richard Edelstein, MD, is 
a fellow in vascular and 
interventional radiology. He 
completed a four-year diag- 
nostic radiology residency at 
Mallinckrodt Institute of 
Radiology and is a member 
of Alpha Omega Alpha. 
Matthew Fleishman, MD, 
instructor in radiology, is a 
fellow in chest radiology. He 
completed a four-year diag- 
nostic radiology residency at 
Mallinckrodt Institute of 
Radiology. Fleishman is a 
member of Alpha Omega 
Alpha. 
Jeffrey Friedland, MD, 
instructor in radiology, is a 
fellow in pediatric radiology. 
He completed a four-year 
diagnostic radiology resi- 
dency at Mallinckrodt Insti- 
tute of Radiology. He is a 
member of Alpha Omega 
Alpha. 
David Gius, MD, PhD, 
instructor in radiology, is the 
1996-1997 American Society 
for Therapeutic Radiology 
and Oncology (ASTRO) fel- 
low in radiation oncology. 
He completed two years of 
residency in radiation oncol- 
ogy at Mallinckrodt Institute 
of Radiology. 
Annette Johnson, MD, 
instructor in radiology, is a 
fellow in neuroradiology. 
She received an undergradu- 
ate degree from The College 
of William and Mary, 
Williamsburg, Virginia, and a 
medical degree from The 
Medical College of Virginia. 
Johnson completed four 
years of training in diagnos- 
tic radiology at Glessinger 
Medical Center, Danville, 
Pennsylvania. 
David Linkhous, MD, 
instructor in radology, is a 
fellow in musculoskeletal 
radiology. He received an 
undergraduate and a medical 
degree from the University 
of Virginia, Charlottesville. 
Linkhous completed an 
internship at Letterman 
Army Medical Center, San 
Francisco, California, and a 
diagnostic radiology resi- 
dency at the University of 
California, San Francisco. 
Lee Madeline, MD, instruc- 
tor in radiology, is a fellow in 
neuroradiology. He received 
an undergraduate degree 
from the University of Michi- 
gan, Ann Arbor, and a med- 
ical degree from Vanderbilt 
University, Nashville, Ten- 
nessee. Madeline completed 
a four-year diagnostic radiol- 
ogy residency at Bowman 
Gray Medical College, Win- 
ston-Salem, North Carolina. 
He is a member of Alpha 
Omega Alpha. 
FOCAL SPOT, SUMMER 1996 19 
THE DIRECTOR'S 
OFFICE REPORT 
Continued from page 19 
Eric Maiden, MD, instruc- 
tor in radiology, is a fellow in 
vascular and interventional 
radiology. He completed 
four years of training in diag- 
nostic radiology at Mallinck- 
rodt Institute of Radiology. 
Randolph Pawluk, MD, 
instructor in radiology, is a 
fellow in magnetic reso- 
nance imaging. He received 
undergraduate and medical 
degrees from the University 
of Alberta, Edmonton. 
Pawluk completed an intern- 
ship at the Royal Alexandra 
Hospital, Alberta, Edmonton, 
Canada, and a residency at 
the University of Alberta 
Hospital. He is a member of 
Alpha Omega Alpha. 
Rory Satterfield, MD, 
instructor in radiology, is a 
fellow in abdominal radiol- 
ogy. He completed a four- 
year diagnostic radiology 
residency at Mallinckrodt 
Institute of Radiology. 
Michele Semin, MD, 
instructor in radiology, is a 
fellow in abdominal radiol- 
ogy. She completed four 
years of training in diagnos- 
tic radiology at Mallinckrodt 
Institute of Radiology. 
Farid Shafaie, MD, instruc- 
tor in radiology, is a fellow in 
neuroradiology. He received 
undergraduate degrees from 
the University of Texas, San 
Antonio, and from the Uni- 
versity of Delaware, Newark, 
and a medical degree from 
Eastern Virginia Medical 
School, Norfolk. Shafaie 
completed a four-year diag- 
nostic radiology residency at 
Eastern Virginia Medical 
School Hospital, Norfolk. 
He is a member of Alpha 
Omega Alpha. 
Mel Sharafuddin, MD, 
instructor in radiology, is a 
fellow in vascular and inter- 
ventional radiology. He 
received undergraduate and 
medical degrees from the 
University of Beirut, 
Lebanon. Sharafuddin com- 
pleted an internship at the 
University of Iowa Hospital 
and Clinics, Iowa City, and a 
residency at St. Louis Uni- 
versity Health Sciences Cen- 
ter, St. Louis, Missouri. He 
is a member of Alpha Omega 
Alpha. 
Leland Tsao, MD, instruc- 
tor in radiology, is a fellow 
in magnetic resonance imag- 
ing. He received an under- 
graduate degree from the 
University of Virginia, Char- 
lottesville, and a medical 
degree from the Medical 
College of Virginia, Rich- 
mond. Tsao completed an 
internship at the Mayo 
Clinic, Rochester, Min- 
nesota, and a four-year diag- 
nostic radiology residency at 
Vanderbilt University, 
Nashville, Tennessee. He is 
a member of Alpha Omega 
Alpha. 
Farrel VanWagenen, MD, 
instructor in radiology, is 
a fellow in vascular and 
interventional radiology. 
He completed four years 
of training in diagnostic 
radiology and was cochief 
resident, 1995-1996, at 
Mallinckrodt Institute of 
Radiology. VanWagenen is 
a member of Alpha Omega 
Alpha. 
Steven Winn, MD, instruc- 
tor in radiology, is a fellow 
in abdominal radiology. He 
completed three years of 
training in diagnostic radiol- 
ogy at Mallinckrodt Institute 
of Radiology. Winn is a 
member of Alpha Omega 
Alpha. 
Robert Wissman, MD, 
instructor in radiology, is a 
fellow in musculoskeletal 
radiology. He received an 
undergraduate degree from 
the University of Cincinnati 
and a medical degree from 
Ohio State University, 
Columbus. Wissman com- 
pleted a four-year diagnostic 
radiology residency at Ohio 
State University, Columbus. 
FIRST-YEAR POSTGRADUATES 
Mark Fister, MD, assistant 
in radiology, received an 
undergraduate degree from 
the University of Illinois, 
Urbana, and a medical 
degree from the University 
of Kentucky, Lexington. He 
is a member of Alpha Omega 
Alpha. 
Jon Fromke, MD, assistant 
in radiology, received an 
undergraduate degree from 
Wheaton College, Illinois, 
and a medical degree from 
University of Minnesota, 
Minneapolis. He is a mem- 
ber of Alpha Omga Alpha. 
Mark Oswood, MD, assis- 
tant in radiology, received an 
undergraduate degree from 
St. Olaf College, Northfield, 
Minnesota, and a medical 
degree from Yale University, 
New Haven, Connecticut. 
Bartosz Rydzewski, MD, 
assistant in radiology, 
received an undergraduate 
degree from K. Marcinkowski 
Memorial, Poznan, Poland, 
and a medical degree from 
Vanderbilt University, 
Nashville, Tennessee. He is 




Donald Blair, MD, assistant 
in radiology, received an 
undergraduate degree from 
the University of Chicago 
and a medical degree from 
Columbia College of Physi- 
cians and Surgeons, New 
York City. He completed a 
one-year transitional intern- 
ship at the University of 
Hawaii, Honolulu. 
Mary Board, MD, assistant 
in radiology, received an 
undergraduate degree from 
Miami University, Oxford, 
Ohio, and a medical degree 
from Washington University 
St. Louis, Missouri. She 
completed a one-year intern 
ship at BarnesJewish 
Hospital, St. Louis, Missouri 
Hank Chen, MD, assistant 
in radiology, received an 
undergraduate degree from 
the University of California, 
Berkeley, and a medical 
degree from University of 
California, Los Angeles. He 
completed a one-year intern 
ship at St. Vincent's Hospital 
New York City. Chen is a 
member of Alpha Omega 
Alpha. 
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Timothy Davis, MD, assis- 
tant in radiology, received an 
undergraduate degree from 
Indiana University, Bloom- 
ington; a masters degree and 
i doctorate from Massachu- 
setts Institute of Technology, 
Cambridge; and a medical 
degreefrom Harvard Univer- 
sity, Cambridge, 
/lassachusetts. 
Terry Falk, MD, assistant 
in radiology, received an 
undergraduate degree from 
University of North Dakota, 
Grand Forks, and a medical 
degree from Universit of 
Minnesota, Minneapolis. He 
completed a one-year transi- 
tional internship at Hennepin 
County Medical Center, min- 
fneapolis, Minnesota. Falk is 
a member of Alpha Omega 
Alpha. 
Anthony Hein, MD, assis- 
tant in radiology, received an 
undergraduate degree from 
Stanford University, Califor- 
nia, and a medical degree 
from University of Califor- 
nia, Los Angeles. He com- 
pleted an internship at 
Cedars-Sinai Medical Center, 
Los Angeles, California. 
Hein is a member of Alpha 
Omega Alpha. 
David Jeck, MD, assistant 
in radiology, received an 
undergraduate degree from 
University of Pennsylvania, 
Philadelphia, and a medical 
degree from the University 
of Arizona, Tucson. He com- 
pleted an internship at Good 
Samaritan Regional Center, 
Tucson. Jeck is a member of 




Alfred Tinger, MD, is the 
1996-1997 radiation 
oncology chief resident. 
He received an under- 
graduate degree in 
physics from the State 
University of New York 
at Binghamton and a 
medical degree from the 
State University of New 
York Health Center at 
Brooklyn. 
Leo Lawler, MD, assistant 
in radiology, received an 
undergraduate and a medical 
degree from the University 
of Dublin, Ireland. He com- 
pleted an internship at St. 
Vincent's University 
Hospital, Dublin, Ireland, 
and at Mayo Clinic, 
Rochester, Minnesota. 
Jason Levy, MD, assistant 
in radiology, received an 
undergraduate degree from 
Washington University, St. 
Louis, Missouri, and a med- 
ical degree from New York 
University, New York. He 
completed an internship at 
Lenox Hill Hospital, New 
York City. 
Pratik Mukherjee, MD, 
assistant in radiology, 
received an undergraduate 
degree from Yale University, 
New Haven, Connecticut, 
and a medical degree from 
Cornell, University, Ithaca, 
New York. He completed an 
internship at New York 
Hospital, 
Harold Prow, MD, assistant 
in radiology, received an 
undergraduate degree from 
Vanderbilt University, 
Nashville, Tennesse, and a 
medical degree from Baylor 
University, Waco, Texas. He 
completed an internship at 
the University of Hawaii, 
Honolulu. Prow is a member 
of Alpha Omega Alpha. 
Agnes Santosa, MD, assis- 
tant in radiology, received 
an undergraduate degree 
from Massachusetts Institute 
of Technology, Cambridge, 
and a medical degree from 
Stanford University, Califor- 
nia. She completed anin- 
ternship at Kaiser 
Permanente, Santa Clara, 
California. 
Stephen Schmitter, MD, 
assistant in radiology, 
received an undergraduate 
degree from University of 
Michigan, Ann Arbor, and a 
medical degree from Stan- 
ford University, California. 
He completed an internship 
at Mercy Hospital and Med- 
ical Center, San Diego, 
California. 
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FIRST-YEAR NUCLEAR 
MEDICINE TRAINEES 
Edward Grishaw, MD, 
assistant in radiology, 
received an undergraduate 
degree from the University 
of Texas, San Antonio, and a 
medical degree from the Uni- 
versity of Texas Health Sci- 
ence Center, San Antonio. 
He completed a four-year 
diagnostic radiology resi- 
dency at Bowman Gray 
School of Medicine, Win- 
ston-Salem, North Carolina. 
Grishaw is a member of 
Alpha Omega Alpha. 
Anton Johnson, MD, assis- 
tant in radiology, received an 
undergraduate degree and a 
medical degree from Univer- 
sity of Minnesota, Minneapo- 
lis. He completed a 
four-year diagnostic radiol- 
ogy residency at University 
of Minnesota,Minneapolis. 
Johnson is a member of 
Alpha Omega Alpha. 
Brigid Gordon, MD, assis- 
tant in radiology, received an 
unergraduate degree from 
Chestnut Hill College, 
Philadelphia, Pennsylvania, 
and a medical degree from 
Georgetown University, 
Washington, DC. She com- 
pleted a four-year diagnostic 
radiology residency at Duke 
University Medical Center, 
Durham, North Carolina. 
Gordon is a member of 
Alpha Omega Alpha. 
Louis Winner, MD, assis- 
tant in radiology, received an 
undergraduate degree from 
Emory University, Atlanta, 
Georgia, and a medical 
degree from University of 
Texas, Dallas. He completed 
an internship and a resi- 
dency at Baylor University 




Samuel Au, MD, PhD, 
assistant in radiology, 
received an undergraduate 
degree from Massachusetts 
Institute of Technology, 
Cambridge; a masters degree 
from University of Southern 
California, Los Angeles; a 
masters degree and a doctor- 
ate degree from University 
of Illinois, Urbana; and a 
medical degree from Univer- 
sity of California, Davis. He 
completed an internship at 
San Bernadino County Med- 
ical Center, California. 
Heather Curry, MD, assis- 
tant in radiology, received an 
undergraduate degree from • 
Bryn Mawr College, Bryn 
Mawr, Pennsylvania, and a 
medical degree from Temple 
University, Philadelphia, 
Pennsylvania. She com- 
pleted an internship at 
Abington Hospital, Abington, 
Pennsylvania. 
Noushin Izadifar, MD, 
assistant in radiology, 
received a medical degree 
from Shiraz University, Shi- 
raz, Iran. She completed a 
transitional internship at 
Ghasm Hospital, Mashad, 
Iran, and six months of resi- 
dency in radiation oncology 
at Jorjani Hospital, Tehran, 
Iran. 
Dotun Oyedijo, MD, assis- 
tant in radiology, received an 
undergraduate and a medical 
degree from University of 
Michigan, Ann Arbor. He 
completed an internship at 
Oakwood Hospital and Med- 
ical Center, Dearborn, 
Michigan. 
OFF STAFF 
Kim Baker, MD, instructor 
in radiology, completed a 
two-year fellowship in neu- 
roradiology and has 




Robert Brown, PhD, visit- 
ing professor of radiology, 
Division of Radiological 
Sciences. 
Gregory Cizek, MD, 
instructor in radiology, com- 
pleted a two-year fellowship 
in neuroradiology and has 
entered private practice in 
St. Louis, Missouri. 
Glenn Coates, MD, instruc- 
tor in radiology, completed a 
one-year fellowship in mag- 
netic resonance imaging and 
has accepted a position with 
Wake Radiology, Raleigh, 
North Carolina. 
Wayne Drevets, MD, assis- 
tant professor of radiology, 
Division of Radiological 
Sciences. 
John Felker, MD, assistant 
in radiology, completed four 
years of training in diagnos- 
tic radiology and has 
accepted a position with 
Greenview Regional Hospital 
Radiology Consultants, 
Bowling Green, Kentucky. 
Andrew Fisher, MD, assis- 
tant in radiology, completed 
four years of training in diag- 
nostic radiology and has 
received a body imaging fel- 
lowship at Duke University 
School of Medicine, Durham, 
North Carolina. 
Kenneth Ford, MD, 
instructor in radiology, com- 
pleted a one-year fellowship 
in abdominal radiology and 
has accepted positions as a 
staff radiologist at Baylor 
University Medical Center, 
Waco, Texas, and as medical 
director at Texas Diagnostic 
Imaging Center, Mesquite. 
Anthony Foti, MD, assis- 
tant in radiology, completed 
four years of training in diag- 
nostic radiology and has 
received an abdominal/body 
imaging fellowship at Duke 
University School of Medi- 
cine, Durham, North 
Carolina. 
Donald Frei, MD, instruc- 
tor in radiology, completed a 
two-year fellowship in neu- 
roradiology and has 
accepted a position with 
Texas Neuroradiology PA, 
Dallas. 
Arjun Godhwani, PhD, 
adjunct research associate, 
Division of Radiological 
Sciences. 
PhiUip Gunther, MD, 
instructor in radiology, com- 
pleted a one-year fellowship 
in magnetic resonance imag- 
ing and has accepted a posi- 








Robert Kanterman, MD, 
structor in radiology, com- 
pleted a one-year fellowship 
i vascular and interven- 
f
 tional radiology and has 
accepted a position with St. 
Luke's Hospital, Chester- 
field, Missouri. 
Todd Knapp, MD, assistant 
in radiology, completed one 
year of training in diagnostic 
radiology. 
Keith Kronemer, MD, 
instructor in radiology, com- 
pleted a one-year fellowship 
in pediatric radiology and 
has accepted a position with 
| Christ Hospital Medical Cen- 
)    1 ter, Oak Lawn, Illinois. 
Cenneth Larson, PhD, 
| research associate, Division 
of Radiological Sciences. 
I Henry Lee, MD, instructor 
in radiology, has accepted a 
position with The Radiation 
| Oncology Center of Las 
Vegas, Sunrise Hospital, Las 
:
 Vegas, Nevada. 
Stephen Loehr, MD, assis- 
tant in radiology, completed 
one year of training in diag- 
nostic radiology. 
Gary Luker, MD, instructor 
in radiology, completed four 
years of training in diagnos- 
tic radiology and a one-year 
fellowship in pediatric radi- 
ology. He has accepted a 
position with Mallinckrodt 
Institute of Radiology, St. 
Louis, Missouri. 
Kevin McEnery, MD, Assis- 
tant professor of radiology, 
Division of Diagnostic Radi- 
ology, has accepted a posi- 
tion with M.D. Anderson 
Cancer Center, Houston, 
Texas. 
Mitchell Miller, MD, instruc- 
tor in radiology, completed a 
four-year diagnostic radiology 
residency and a one-year fel- 
lowship in abdominal radiol- 
ogy. He has accepted a 
position with Atlantic Radiolo- 
gists, Domona, New Jersey. 
Astrid Morrison, MD, assis- 
tant in radiology and chief res- 
ident, Radiation Oncology 
Center, 1995-1996, completed 
three years of residency and a 
one-year fellowship in radia- 
tion oncology. She has 
entered private practice in 
Oklahoma City, Oklahoma. 
John Moyers, MD, assistant 
in radiology, completed one 
year of training in nuclear 
medicine and has entered pri- 
vate practice in Nashville, 
Tennessee. 
Sean Muldowney, MD, 
instructor in radiology and 
cochief resident, Division of 
Diagnostic Radiology, 1994- 
1995, completed four years of 
training in diagnostic radiol- 
ogy and a one-year fellowship 
in vascular and interventional 
radiology. He has accepted a 
position with Mori, Bean & 
Brooks, PA, Jacksonville, 
Florida 
Theodore Passe, MD, assis- 
tant in radiology, completed 
one year of training in diag- 
nostic radiology. 
Charles Pringle, MD, assis- 
tant in radiology, completed 
one year of training in nuclear 
medicine and has accepted a 
position with Radiological 
Group, PA, Jackson, 
Mississippi. 
Valerie Reichert, MD, 
instructor in radiology, com- 
pleted a four-year diagnostic 
radiology residency and a 
one-year fellowship in 
abdominal radiology. She has 
accepted a position with St. 
Luke's Hospital, Chesterfield, 
Missouri. 
Michael Roarke, MD, assis- 
tant in radiology, completed 
a four-year diagnostic radiol- 
ogy residency and one year 
of training in nuclear medi- 
cine. He has accepted a posi- 
tion with Lyndon B. Johnson 
General Hospital, University 
of Texas, Houston. 
Francis Schlueter, MD, 
instructor in radiology, com- 
pleted a four-year diagnostic 
radiology residency and a 
one-year fellowship in vascu- 
lar and interventional radiol- 
ogy. He has accepted a 
position with Good Samari- 
tan Hospital, Cincinnati, 
Ohio. 
Ken Schreibman, MD, 
PhD, instructor in radiology, 
completed a one-year fellow- 
ship in musculoskeletal radi- 
ology and has accepted a 
position with the University 
of Mississippi Medical Cen- 
ter, Jackson. 
Gregg Schubach, MD, 
assistant in radiology, com- 
pleted one year of training in 
nuclear medicine and has 
accepted a position with 
Progressive Physician Asso- 
ciates, Easton, Pennsylvania. 
Sharon Schubach, MD, 
instructor in radiology, com- 
pleted a one-year fellowship 
in breast imaging. 
Kurt Simpson, MD, 
instructor in radiology, com- 
pleted four years of training 
in diagnostic radiology and a 
one-year fellowship in vascu- 
lar and interventional radiol- 
ogy. He has accepted a 
position with the University 
of Wisconsin, Clinical Sci- 
ence Center,Madison. 
Isabel Soroeta, MD, 
instructor in radiology, com- 
pleted a one-year fellowship 
in breast imaging and has 
accepted a positionwith 
Barnes-Jewish West County 
Hospital, Creve Coeur, Mis- 
souri. 
Jeffrey Spaeder, MD, 
assistant in radiology, com- 
pleted one year of training in 
diagnostic radiology and has 
entered the internal medi- 
cine residency program at 
Johns Hopkins Hospital, Bal- 
timore, Maryland. 
Glenn Strome, MD, 
instructor in radiology, com- 
pleted a one-year fellowship 
in musculoskeletal radiology 
and has accepted a position 
with Erlanger Memorial 
Medical Center, Chat- 
tanooga, Tennessee. 
Avinash Sud, MD, instruc- 
tor in radiology, completed a 
two-year fellowship in neu- 
roradiology and accepted a 
position with St. Jude Radi- 
ology medical Group, Inc., 
Fullerton, California. 
Robert Swanson, MD, 
assistant in radiology, com- 
pleted four years of resi- 
dency in radiation oncology, 
and has accepted a position 
with United States Air Force 
Medical Center, Biloxi, 
Mississippi. 
Alexander Tsiaras, visiting 
research associate, Division 
of Radiological Sciences. 
Michael Wallace, MD, 
instructor in radiology, com- 
pleted a one-year fellowship 
in vascular and interven- 
tional radiology and has 
accepted a position with the 
University of Texas South- 
western Medical School, 
Dallas. 
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Eric Weidman, MD, assis- 
tant in radiology and chief 
resident, Division of Diag- 
nostic Radiology, 1995-1996, 
completed a four-year diag- 
nostic radiology residency 
and has accepted a position 
with the David Grant Med- 
ical Center at Travis Air 
Force Base, Fairfield, 
California. 
Pamela Woodard, MD, 
instructor in radiology, com- 
pleted a one-year fellowship 
in chest radiology and has 
accepted a position with 
Mallinckrodt Institute of 
Radiology. 
Neda Yagan, MD, assistant 
in radiology, completed a 
four-year diagnostic radiol- 
ogy residency and has 
accepted a positionwith the 
University of Pittsburgh 
Medical Center, Pittsburgh, 
Pennsylvania. 
Tongzeng Yang, PhD, 
instructor in radiology, Divi- 
sion of Radiological 
Sciences. 
Terry Yeager, MD, instruc- 
tor in radiology, completed a 
one-year fellowship in vascu- 
lar and interventional radiol- 
ogy and has accepted a 
position with Tripler Army 
Medical Center, Honolulu, 
Hawaii. 
Anthony Zelazny, MD, 
assistant in radiology, com- 
pleted four years of training 
in diagnostic radiology and 
has received a musculoskele- 
tal fellowship at the Univer- 
sity of Wisconsin Hospital 
and Clinics, Madison. 
Tinko Zlatev, MD, assistant 
in radiology, completed four 
years of training in diagnos- 
tic radiology and has 
accepted a position with 
Haywood County Hospital, 
Clyde, North Carolina. 
Jeffrey Brown, MD, associ- 
ate professor of radiology, 
was appointed to the Roster 
of Distinguished Scientific 
Advisors for the Radiological 
Society of North America's 
Research and Education 
Fund. 
Louis Gilula, MD, professor 
of radiology and director of 
musculoskeletal radiology, 
was elected as membership 
chairman for the American 
Society for Musculoskeletal 
Radiology. He was 
appointed as examiner for 
the Musculoskeletal Section 
of the Diagnostic Radiology 
Oral Boards, Louisville, Ken- 
tucky, June 9-12. 
Lawrence Kotner, MD, 
associate professor of radiol- 
ogy, was appointed to a one- 
year term as a medical staff 
representative to the Medical 
Executive Committee of 
Barnes-Jewish Hospital. 
Daniel Low, PhD, assistant 
professor of radiology, was 
appointed to a two-year term 
on the Board of Representa- 
tives for the Missouri River 
Valley Chapter of the Ameri- 
can Association of Physicists 
in Medicine. 
Jeff Michalski, MD, assis- 
tant professor of radiology, 
and Barry Siegel, MD, pro- 
fessor of radiology and 
director of the Division of 
Nuclear Medicine, were 
appointed cochairmen of the 
Protocol Review and Moni- 
toring Committee of the 
Washington University Can- 
cer Center. 
Tom Miller, MD, PhD, was 
elected as a member of the 
House of Delegates of the 
Society of Nuclear Medicine. 
Scott Mirowitz, MD, asso- 
ciate professor of radiology, 
co director of body MRI, and 
chief of radiology at Barnes- 
Jewish Hospital - North Cam- 
pus, was appointed editor of 
Magnetic Resonance Imag- 
ing Clinics of North 
America. 
Douglas Robertson, MD, 
PhD, assistant professor of 
radiology and of orthopedic 
surgery, was appointed to 
the Public Affairs Committee 
of the St. Louis Regional 
Commerce and Growth 
Association. 
Joseph Roti Roti, PhD, 
professor of radiology, asso- 
ciate director of the Radia- 
tion Oncology Center, and 
chief of cancer biology, was 
appointed to the State of 
Nebraska Department of 
Health's Technical Review 
Panel for the Cancer and 
Smoking Disease Research 
Program. He also was 
appointed as a reviewer for 
the IEEE Standards Coordi- 
nating Committee 28, Sub- 
committee 4, In vitro 
Literature Review Working 
Group. 
Peter Shile, MD, PhD, 
assistant professor of radiol 
ogy, was appointed as a clin 
ical reviewer for the 
American College of Radiol- 
ogy Stereotactic Breast 
Biopsy Accreditation Pro- 
gram. He also was 
appointed to a three-year 
term on the American Roenl 
gen Ray Society Scientific 
Program Committee for 
Breast Imaging. 
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Barry Siegel, MD, professor 
of radiology and director of 
the Division of Nuclear Medi- 
cine, was appointed by the 
United States Pharmacopeia 
Division of Information 
Development to a five-year 
term on the Radiopharmaceu- 
ticals Expert Advisory Panel. 
The multidisciplinary panel 
will develop and approve 
drug and therapeutics infor- 
mation and contribute to any 
decisions relating to 
radiopharmaceuticals. 
Marilyn Siegel, MD, profes- 
sor of radiology, was 
appointed to a three-year term 
as a member of the Conven- 
tion Program Committee of 
the American Institute of 
Ultrasound Medicine. 
Celette Skinner, PhD, assis- 
tant professor of radiology, 
was appointed as a member of 
the Prevention and Control 
and Human Cancer Genetics 
Research Programs, Washing- 
ton University Cancer Center. 
Clark West, MD, assistant 
professor of radiology and 
director of emergency and 
trauma radiology, was 
appointed to a one-year term 
as chairman of the Member- 
ship Committee for the Ameri- 
can Society of Emergency 
Radiology. 
Jeffrey Williamson, PhD, 
professor of radiology and 
chief of brachytherapy 
physics, was elected as a fel- 
low of the American Associa- 
ion of Physicists in Medicine, 
le was appointed to the U.S. 
Nuclear Regulatory Commis- 
sion Advisory Committee on 
ledical Use of Isotopes. 
Franz Wippold, MD, associ- 
ate professor of radiology, 
was appointed as guest inves- 
igator for the Armed Forces 
stitute of Pathology's study 
on spinal cord tumors. 
MIR Education Center 
Joe Quennoz, Dave Smugala, and David Piper of the MIR 
plant facilities team are renovating space on the fourth 
floor of the Old Children's Annex in preparation for the 
Education Center's move from the Institute's 10th floor. 
FELLOWSHIPS/ 
GRANTS 
Thomas Conturo, MD, 
PhD, assistant professor of 
radiology, as principal inves- 
tigator, received a $300,000 
grant from the McDonnell 
Center for Higher Brain 
Function Major Grants 
Program for his research on 
"Functional neuronal imag- 
ing with magnetic resonance 
in humans and primates." 
Coinvestigators on the three- 
year grant are Marcus 
Raichle, MD, codirector of 
the Division of Radiological 
Sciences; Avi Snyder, PhD, 
MD, Department of Neurol- 
ogy; Robert McKinstry, 
MD, PhD, assistant in radiol- 
ogy; Harold Burton, PhD, 
Department of Anatomy and 
Neurobiology; Tongzeng 
Yang, PhD, instructor in 
radiology; and Erbil Akbu- 
dak, PhD, graduate research 
assistant in radiology. 
Duffy Cutler, PhD, assis- 
tant professor of radiology, 
received a three-year grant 
in the amoutn of $524,998 for 
research on "Radiation 
dosimetry of Cu-64-labeled 
radiotherapy agents using 
positron emission 
tomography." 
Mokhtar Gado, MD, pro- 
fessor of radiology, received 
a five-year grant grant from 
the National Institutes of 
Health for research on mag- 
netic resonance imaging of 
the structural brain changes 
associated with cognitive 
changes due to cerebrovas- 
cular disease. 
Marshall Hicks, MD, asso- 
ciate professor of radiology, 
received a Seed Grant Award 
from the Radiological Soci- 
ety of North America's 
Research and Education 
Fund. The one-year grant 
will support research in 
"Interventional and vascular 
techniques for hepatic gene 
therapy." 
0CAL SPOT, SUMMER 1996 25 
FELLOWSHIPS/ 
GRANTS 
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Weili Lin, PhD, assistant 
professor of radiology, 
received a four-year grant in 
the amount of $791,233 from 
the National Institute of 
Neurological Disorders and 
Stroke for research on "Tis- 
sue water measurements of 
brain edema with MRI." 
Daniel Low, PhD, assistant 
professor of radiology, 
received the 1996 American 
Association of Physicists in 
Medicine Travel Award, pre- 
sented at the AAPM's annual 
meeting in July in Philadel- 
phia. The award will sup- 
port Low's travels to Great 
Britain, where he will pre- 
sent invited lectures at sev- 
eral universities. 
Gary Luker, MD, instructor 
in radiology, received a one- 
year RSNA Fellowship sup- 
ported by Mallinckrodt 
Medical Inc. from the Radio- 
logical Society of North 
America's Research and 
Education Fund. The 
$30,000 grant was awarded 
for Luker's research in 
"Characterization of Tc99m- 
N2O2P2 complexes for func- 
tional imaging of multidrug 
resistance in cancer." For 
this same research, Luker 
also received a one-year, 
$30,000 grant from the Soci- 
ety of Nuclear Medicine. 
Douglas Robertson, MD, 
PhD, assistant professor of 
radiology and of orthopedic 
surgery, received a three- 
year Whitaker Foundation 
Biomedical Research Grant 
in the amount of $210,000 
for research on "Modeling 
and analysis of acetabular 
defects caused by failed hip 
prostheses." 
Celette Skinner, PhD, 
assistant professor of radiol- 
ogy, as principal investiga- 
tor, received a $20,000 
one-year grant from the 
Barnard Hospital Board for 
research on "Beliefs about 
breast cancer, risk factors 
and personal risk, and pref- 
erences regarding risk coun- 
seling among low-income 
African-American women in 
urban St. Louis." 
Ge Wang, PhD, assistant 
professor of radiology, 
received a $543,628 five-year 
grant from the National 
Institute of Diabetes and 
Digestive and Kidney Dis- 
eases for the research pro- 
ject "Unraveling the GI Tract 
by Spiral CT." Michael 
Vannier, MD, professor of 
radiology and chief of the 
image processing lab, is 
coinvestigator. 
Michael Vannier, MD, pro- 
fessor of radiology and chief 
of the image processing lab, 
received a $1,251,152 grant 
from the National Institute 
of Neurological Disorders 
and Stroke. The five-year 
grant will fund the research 
project "Normal MR neuro- 
morphometry by global pat- 
tern matching." 
Jeffrey Williamson, PhD, 
professor of radiology and 
chief of brachytherapy 
physics, received a three- 
year grant from the National 
Cancer Institute for 
"Brachytherapy dosimetry 
using plastic scintillator." 
Coinvestigators for the 
$752,000 grant are Robert 
Binns, PhD, Washington Uni- 
versity Department of 
Physics; Assen Kirov, MS; 
John Wong, PhD, William 
Beaumont Hospital, Royal 
Oaks, Michigan; and Charles 
Hurlbut, Epikon, Inc., Bed- 
ford Heights, Ohio. 
Pamela Woodard, MD, 
instructor in radiology, 
received the 1996 Siemens 
Medical Systems/RSNA Fel- 
lowship from the Radiologi- 
cal Society of North 
America's Research and 
Education Fund. The one- 
year $30,000 fellowship will 
support her research project 
"Identification of proximal 
coronary artery stenosis 
with 3D MR retrospective 
respiratory gating." 
Woodard also received an 
American Heart Association 
Fellows Grant for her 





Carolyn Anderson, PhD, 
assistant professor of radiol- 
ogy, was an invited instruc- 
tor at the Summer School in 
Nuclear Chemistry, a 
Department of Energy-spon- 
sored program for under- 
graduates in chemistry, at 
San Jose State University, 
San Jose, California, July 8 - 
12. 
Ty Bae, MD, PhD, assistant 
in radiology, received a 
$25,000 Research Resident 
Award from the Radiological 
Society of North America's 
Research and Education 
Fund. The one-year award 
will support Bae's research 
project "Optimization of 
contrast enhancement dur- 
ing spiral CT: effect of alter- 
ations in cardiovascular 
physiology." 
Evren Senol, graduate 
research assistant, received 
first prize in the Washington 
University Research Fair, 
sponsored by the Associa- 
tion of Graduate Engineer- 
ing Students. 
1 
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)iagnostic 
Radiology 
Donald Heck, MD, and Thomas 
Vaughan, MD, (seated) are the diag- 
nostic radiology chief residents for 
1996-1997. Heck received a med- 
ical degree from Duke University; 
Vaughan is an alumnus of Washing- 
ton University School of Medicine. 
LECTURES/ 
PRESENTATIONS 
Carolyn Anderson, PhD, 
assistant professor of radiol- 
ogy, presented "Preclinical 
internal emitter therapy stud- 
ies with Cu-64 and Cu-67 
labeled antibodies and pep- 
tides" at the Los Alamos 
National Laboratory, Los 
Jamos, New Mexico, June 7. 
larold Bennett, MD, PhD, 
ssistant professor of radiol- 
ogy, presented "Role of radi- 
ology in detection and 
staging of colorectal cancer" 
at the 8th Annual American 
Dancer Society Program on 
3reast and Colorectal Can- 
cer, Memorial Hospital of 
Carbondale, Illinois, April 27. 
James Blaine, DSc, profes- 
sor of radiology and chief of 
the electronic radiology lab, 
presented a tutorial, "Select- 
ing networks for health data 
and images," at the American 
Medical Informatics Associa- 
tion's 1996 Spring Congress, 
Kansas City, Missouri, 
June 5 - 8. 
Walter Bosch, DSc, instruc- 
tor in radiology, spoke on 
"Data management for 3D 
CRT" at the 38th Annual 
Meeting of the American 
Association of Physicists in 
Medicine, Philadelphia, 
Pennsylvania, July 23. 
James Brink, MD, associate 
professor of radiology and 
codirector of computed body 
tomography, presented "Spi- 
ral CT angiography" and 
"Contrast media physiology: 
emphasis on hepatic imag- 
ing" at the Siemens CT Users' 
Meeting, Scottsdale, Arizona, 
June 7 and 8. 
Farrokh Dehdashti, MD, 
assistant professor of radiol- 
ogy, presented "Breast imag- 
ing with PET" and "Epilepsy 
imaging with PET" at the 
Feasibility of PET Imaging 
Symposium, Institute of 
Radiological Science, Mater 
Hospital, Dublin, Ireland, 
April 15. 
Bahman Emami, MD, pro- 
fessor of radiology, spoke on 
"RTOG protocol 93-11/three- 
dimensional conformal radio- 
therapy of lung cancer: 
rationale for new dose esca- 
lation study schema" at the 
IASLC Workshop - Contro- 
versies in Staging and Com- 
bined Treatment Modalities 
in Lung Cancer, Bruges, Bel- 
gium, June 23 - 27. Repre- 
sented "Squamous cell 
carcinoma of the floor of 
mouth: evaluation of long- 
term results and prognostic 
factors" and "Squamous cell 
carcinoma of the oral tongue: 
evauation of long-term 
results and prognostic fac- 
tors" at the 4th International 
Conference on head and 
Neck Cancer, Toronto, 
Ontario, Canada. 
Keith Fischer, MD, associ- 
ate professor of radiology, 
spoke on "Scintigraphic 
markers of outcome after 
lung volume reduction 
surgery as assessed with pre- 
operative lung scans" at the 
American Roentgen Ray 
Society 96th Annual Meeting, 
San Diego, California, May 5 - 
10. 
David Gierada, MD, 
instructor in radiology, pre- 
sented "Dynamic MR imaging 
to analyze respiratory 
mechanics in patients having 
lung volume reduction 
surgery," which received a 
Certificate of Merit Award; 
"Atelectatic pseudomass in 
severe bullous emphysema," 
and "Dynamic MR imaging of 
respiratory coordination 
before and after lung volume 
reduction surgery" to the 
American Roentgen Ray 
Society 96th Annual Meeting, 
San Diego, California, 
May 5 -10. 
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Louis (iilula, MD, profes- 
sor of radiology and chief of 
musculoskeletal radiology, 
lectured on "Imaging 
approach to wrist pain" at 
The 86th Congress of the 
Central Japan Association of 
Orthopaedic Surgery and 
Traumatology, Nara, Japan, 
May 30 and 31. As visiting 
professor, he spoke on 
"Plain film approach to mus- 
culoskeletal tumors" and 
"Radiographic interpretation 
of ligament instabilities of 
the wrist" at the Fukuoka 
University School of Medi- 
cine, Fukuoka, Japan, June 
3. Gilula lectured on 
"Arthrography and CT 
arthrography," "Roentgeno- 
graphic approach to hand 
and wrist pain," "Percuta- 
neous bone biopsy," and 
"MRI of wrist and hand" at 
the Advance Course in Mus- 
culoskeletal Radiology, 
Margherita di Savoia, Italy, 
June 21-23. 
Harvey Glazer, MD, profes- 
sor of radiology, presented 
the instructional course "Pit- 
falls in the radiological diag- 
nosis of bronchogenic 
carcinoma" at the American 
Roentgen Ray Society 96th 
Annual Meeting, San Diego, 
California, May 5 -10. 
Mary Graham, MD, assis- 
tant professor of radiology, 
spoke on "Multimodality 
treatment of esophagus can- 
cer," "Radiation therapy for 
lung cancer," and "New tech- 
nology in radiation therapy - 
maximize the potential" at 
the Southern California ACS 
Traveling Oncologist Lecture 
Series, Los Angeles, Califor- 
nia, June 3 - 7. 
Jay Heiken, MD, professor 
of radiology and chief of 
abdominal radiology, pre- 
sented "Colorectal carci- 
noma: detection, staging, 
and follow-up," "CT and MRI 
evaluation of gynecologic 
neoplasms," and "Testicular 
germ cell neoplasms: detec- 
tion, staging, and follow-up" 
to the Annual Meeting of the 
Oklahoma State Radiological 
Society, Oklahoma City, 
Oklahoma, April 12 and 13. 
He presented "Diffuse Dis- 
eases of the Liver" at the Cat- 
egorical Course on Radiology 
of the Liver, Biliary Tract, 
and Pancreas, at the Ameri- 
can Roentgen Ray Society 
96th Annual Meeting, San 
Diego, California, May 5 -10. 
Eric Klein, MS, assistant 
professor of radiology, 
spoke on "Clinical uses of 
multileaf collimation and 
enhanced dynamic wedge" at 
the Varian Applications 
meeting, Williamsburg, Vir- 
ginia, June 21. 
Weili Lin, PhD, assistant 
professor of radiology, lee- ■ 
tured on "Contrast-enhanced 
magnetic resonance angiog- 
raphy of carotid artery wall 
in pigs" and "Simultaneous 
and quantitative separation 
of Rl and R2 change in vivo 
fMRI using single-shot Gp2" 
at the ISMRM meeting, New 
York City, New York, April 
29 and May 1. 
Daniel Low, PhD, assistant 
professor of radiology, pre- 
sented "Use of physical mod- 
ulators for intensity 
modulated radiation ther- 
apy" at the American Associ- 
ation of Physicists in 
Medicine Annual Meeting, 
Philadelphia, Pennsylvania, 
July 21-25. 
Elizabeth McFarland, MD, 
assistant professor of radiol- 
ogy, presented "Imaging of 
focal liver lesions" at the 
Barnes-Jewish Hospital Med- 
ical Grand Rounds, St. Louis, 
Missouri, May 19. 
Robert McKinstry, MD, 
PhD, assistant in radiology, 
presented "Echo planar 
human diffusion tensor 
imaging with tetrahedral 
encoding" and a poster 
exhibit, "Quantitative mea- 
surements of brain water 
apparent diffusion coeffi- 
cient in healthy full-term 
neonates," to the 4th Annual 
Meeting of the Internationa- 
tional Society for Magnetic 
Resonance in Medicine, New 
York City, April 28 - May 3. 
Eduardo Moros, PhD, 
assistant professor of radiol- 
ogy, spoke on "Lateral con- 
formability and penetration 
depth controllability using 
ultrasound arrays and reflec- 
tors" at the 1996 Surgical 
Application of Energy 
Sources Conference, Estes 
Park, Colorado, May 17 -19. 
He presented "Power deposi- 
tion conformability of the 
SURLAS: a system for exter- 
nal simultaneous thermora- 
diotherapy" to the 7th 
International Congress on 
Hyperthermic Oncology 
Meeting, Rome, Italy, April 9 
-13. Moros presented "The 
radial transmission line as a 
broad-band shielded expo- 
sure system for microwave 
irradiation of large numbers 
of culture flasks" to the 18th 
Annual Meeting of the Bio- 
electromagnetics Society 
(BEMS), Victoria, British 
Columbia, Canada, June 9 - 
14. 
Douglas Robertson, MD, 
PhD, assistant professor of 
radiology and of orthopedic 
surgery, spoke on 
"Advanced technologies 
applied to orthopedic joint 
replacement" at the St. Louis 
Regional Commerce and 
Growth Association, St. 
Louis, Missouri, May 17. 
Joseph Roti Roti, PhD, 
professor of radiology, asso- 
ciate director of the Radia- 
tion Oncology Center, and 
chief of cancer biology, pre- 
sented "Consideration of the 
use of the alkaline comet 
assay for routine screen of 
DNA damage, "Further evi- 
dence that S-phase progres- 
sion is required for 
hyperthermia-induced cell 
death in Hela cells," 
"Chronic thermotolerance 
with continued cell prolifer- 
ation," "Enhanced turnover 
rate of topoisomerase 113 
mRNA by agents known to 
induce G2-delay," and "Dif- 
ferential radioprotection of 
oncogene transfected rat 
embryo ceUs by WR1065 
correlates with DNA super- 
coiling changes" to the 44th 
Annual Meeting of the Radi 
ation Research Society, 
Chicago, Illinois, April 14 - 
17. As invited speaker, he 
lectured on "Nuclear matrc 
mediated DNA organizatior 
and the radioresistance/ser- 
sitivity of transformed cells' 
at the 21st Annual Meeting 
of the Gilbert H. Fletcher 
Society, Williamsburg, Vir- 
ginia, April 18 - 20. Roti Ro 
spoke on "Measurement of 
DNA damage by the alkalint 
comet assay after in vitro 
exposure to 835 Mhz electri 
magnetic radiation," "Lack 
of any significant effects of 
835 Mhz FM or CDMA 
microwave exposure upon 
macromolecular synthesis 
rates, cell growth, or cell 
cycle phase distribution," 
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"Comparison of stereotactic 
and template injection of 
«ethods to implant 9L 
loma cells in the rat brain," 
and "Further characteriza- 
tion and modification of a 
is      chemically induced rat brain 
tumor model for tumor pro- 
motion studies" at the 18th 
Annual Meeting of the Bio- 
electromagnetics Society, 
rictoria, British Columbia, 
lanada, June 9 -14. 
Henry Royal, MD, profes- 
sor of radiology and associ- 
(te director of the Division 
f Nuclear Medicine, pre- 
sented "SNM procedure 
guidelines" to the Mid-east- 
ern Society of Nuclear Medi- 
cine Chapter, Rockville, 
Maryland, April 13. He pre- 
sented the keynote 
address, "Technology assess- 
ment: the good, the bad, and 
the horrific," as well as "Mea- 
suring value: David Jones or 
target" and "Pulmonary 
embolism: Technology 
assessment gone mad!" to 
the Australian and New 
Zealand Society of Nuclear 
Medicine, Ayer's Rock, Aus- 
tralia, June 28 - 30. 
Stuart Sagel, MD, profes- 
sor of radiology and chief of 
chest radiology, spoke on 
'■■"CT of the pleura" and "Role 
of CT and MRI in staging 
bronchogenic carcinoma" at 
the Annual Conference on 
Chest Disease of the Fleis- 
chner Society, Vancouver, 
British Columbia, Canada, 
June 13 -15. 
Jarry Siegel, MD, profes- 
sor of radiology and director 
Df the Division of Nuclear 
fedicine, presented 
"Somatostatin-receptor 
tiaging of neuroendocrine 
lors" to the Catholic Uni- 
versity Graduate School, 
Seoul, Korea, May 13. 
Marilyn Siegel, MD, pro- 
fessor of radiology, spoke on 
"Problems and pitfalls in 
pediatric MRI" and "Pedi- 
atric musculoskeletal MRI" 
at the 19th Annual Course of 
the Society of Computed 
Body Tomography and Mag- 
netic Resonance, Scottsdale, 
Arizona, May 18 - 20. As 
invited lecturer, she pre- 
sented "Recent advances in 
pediatric ultrasound" to the 
Korean Society of Medical 
Ultrasound, Seoul, Korea, 
May 11. As visiting profes- 
sor, Siegel spoke on "Appli- 
cations of duplex and 
colored Doppler sonography 
in the pediatric abdomen" 
and "Duplex and color 
Doppler Sonography of the 
neonatal brain" at the Seoul 
National University Chil- 
dren's Hospital, Seoul, 
Korea, May 13 and 14. She 
chaired a special focus ses- 
son on ultrasonography and 
spoke on "Doppler ultrason- 
igraphy in the acute pedi- 
atric abdomen" and "Breast 
sonography in children" at 
the International Pediatric 
Radiology Meeting, Boston, 
Massachusetts, May 25 - 29. 
Celette Skinner, PhD, 
assistant professor of radiol- 
ogy, as a panel member, pre- 
sented "What we know 
about the effectiveness of 
tailoring" at the initial meet- 
ing of the National Cancer 
Institute's panel on "Tailored 
Messages in Cancer Commu- 
nications", Bethesda, Mary- 
land, July 17. 
Richard Slone, MD, assis- 
tant professor of radiology, 
presented "Radiologic 
assessment of structural fea- 
tures in emphysema" and 
"Comparison of radiologic 
features with clinical data 
and outcome following lung 
volume reduction surgery" at 
the Multidisciplinary Volume 
Reduction Research Meet- 
ing, St. Louis, Missouri, April 
23. He presented "Preopera- 
tive radiologic evaluation 
and patient selection crite- 
rion for lung volume reduc- 
tion surgery," "Common 
pitfalls leading to rejection 
of major papers submitted to 
AIR," and "Preoperative 
radiologic findings in 
patients with an unfavorable 
outcome after lung volume 
reduction surgery" at the 
American Roentgen Ray 
Society 96th Annual Meet- 
ing, San Diego, California, 
May 5 -10. 
Douglas Spitz, PhD, assis- 
tant professor of radiology, 
as guest lecturer, spoke on 
"Mechanisms of resistance 
to oxidative stress" at the St. 
Louis University Health Sci- 
ences Center, St. Louis, Mis- 
souri, April 12. He 
presented "The cytotoxicity 
of anticancer agents in 
H202-resistant hamster 
fibroblasts," "Mechanisms of 
heat resistance in oxidative 
stress resistant cells," and 
"Nitric oxide induced resis- 
tance to oxidative stress" to 
the 44th Annual Meeting of 
the Radiation Research Soci- 
ety, Chicago, Illinois, April 
14 -17. Spitz presented 
"Does 835 MHz FMCW irra- 
diation alter nitric oxide pro- 
duction by the J774.16 
mouse macrophage of cell 
line?", "Comparison of 
stereotactic and template 
injection methods to implant 
9L glioma cells in the rat 
brain," and "Further charac- 
terization and modification 
of a chemically induced rat 
brain tumor model for tumor 
promotion studies" to the 
18th Annual Meeting of the 
Bioelectromagnetics Soci- 
ety, Victoria, British Colum- 
bia, Canada, June 9 -14. 
Alfred Tinger, MD, assis- 
tant in radiology and chief 
resident, Radiation Oncol- 
ogy Center, spoke on 
"Patient motion within an 
immobilization device" at 
the 4th International Confer- 
ence on Electronic Portal 
Imaging, Amsterdam, The 
Netherlands, June 10. 
Jeffrey Williamson, PhD, 
professor of radiology and 
chief of brachytherapy 
physics, as invited speaker, 
presented the refresher 
course "Brachytherapy 
source strength, quantities, 
and calibrations" at the 38th 
Annual American Associa- 
tion of Physicists in Medi- 
cine, Philadelphia, 
Pennsylvania, July 21-25. 
Franz Wippold, MD, asso- 
ciate professor of radiology, 
as visiting professor, spoke 
on "Head and neck imaging 
update" at the National 
Naval Medical Center, 
Bethesda, Maryland; Walter 
Reed Army Medical Center, 
Washington, DC; and Uni- 
formed Services University 
of the Health Services, 
Bethesda, Maryland, April 
29 - May 10. 
Pamela Woodard, MD, 
instructor in radiology, as 
invited lecturer, spoke on 
"Cardiac and thoracic vascu- 
lar imaging: recent develop- 
ments in MR and spiral CT" 
at the St. Louis University 
Health Sciences Center, St. 
Louis, Missouri, April 10. 
She presented "Identifica- 
tion of coronary artery 
stenoses with 3D MR retro- 
spctive respiratory gating" to 
the American Roentgen Ray 
Society 96th Annual Meet- 
ing, San Diego, California, 
May 5 -10. 
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SYMPOSIA 
SOCIETY OF NUCLEAR 
MEDICINE 
The 43rd Annual Meeting 
Denver, Colorado 
June 3 - 5, 1996 
Farrokh Dehdashti, MD, 
as first author, received the 
1996 Outstanding Manu- 
script Award for one of the 
five best papers published in 
the Journal of Nuclear Med- 
icine. The paper, "Positron 
tomographic assessment of 
estrogen receptors in breast 
cancer: comparison with 
FDG-PET and in vitro recep- 
tor assays," was coauthored 
with Barry Siegel, MD; 
Duffy Cutler, PhD; 
Michael Welch, PhD; 
Thomas Bonasera, MA; 
Maureen Fusselman, MS, 
BSN; and Diane Detert, 
CNMT, of Mallinckrodt 
Institute; Joanne Mortimer, 
MD, of Washington Univer- 
sity's Division of Medical 
Oncology; Landis Griffeth, 
MD, PhD, of Baylor Univer- 
sity Medical Center, Waco, 
Texas; and John Katzenel- 
lenbogen, PhD, of the Uni- 
versity of Illinois, Urbana. 
SCIENTIFIC PAPERS 
Carolyn Anderson, PhD, 
moderator, "Radiopharma- 
ceutical chemistry: thera- 
peutic and other nuclides I." 
Duffy Cutler, PhD, comod- 
erator, "Instrumentation and 
data analysis: three-dimen- 
sional PET." 
Farrokh Dehdashti, MD, 
moderator, "Oncology diag- 
nosis (nonantibody): breast 
cancer newer tracers." 





MD, PhD, comoderator, 
"Radiopharmaceutical chem- 
istry: preclinical studies II." 
Barry Siegel, MD, modera- 
tor, "Radiobiology I - 
dosimetry." 
Carolyn Anderson, PhD; 
Judith Connett, PhD*; Carl 
Germain, MS*; Li Guo, MS*; 
Buck Rogers, PhD**; Sally 
Schwarz, RPh, MS; Alan 
Fritzberg, PhD***; Michael 
Welch, PhD, "Cu-64-Labeled 
BAT-21T-NR-LU-10 Fab: an 
agent for PET imaging and 
radioimmunotherapy." 
*Washington University, St. 
Louis, Missouri. ^Univer- 




Carolyn Anderson, PhD; 
Elizabeth Sherman, BA; 
Deborah McCarthy, PhD; 
Laura Bass, PhD; Lynne 
Jones, BA; Michael 
Cristel, MA; Margaret 
Lanahan, MS; Ruth Shefer, 
PhD*; Robert Klinkowstein, 
PhD*; Michael Welch, PhD, 
"Radiotherapy studies of Cu- 
64-labeled teta-octreotide in 
Tumor-bearing rats." *New- 
ton Scientific Inc., Winches- 
ter, Massachusetts. 
Judith Connett, PhD*; Car- 
olyn Anderson, PhD; Li 
Guo, MS*; Sally Schwarz, 
RPh, MS; Carl Germain, 
MS*: Gordon Philpott, MD*; 
Michael Welch, PhD, 
"Long-term radioim- 
munotherapy studies of Cu- 
64 anti-colon carcinoma 
monoclonal antibody (MAb)- 
1A3, intact and F(ab')2 singly 
and in combination in the 
GW39-hamster model." 
*Washington University 
School of Medicine, St. 
Louis, Missouri. 
Duffy Cutler, PhD; Far- 
rokh Dehdashti, MD; 
Barry Siegel, MD; Joanna 
Downer, MS; Michael 
Welch, PhD, "Investigation 
of a prostate ligand 16£-[F- 
18]Fluoro-59-Dihydro-testos- 
terone for staging of 
prostate carcinoma." 
Fidelma Flanagan, MD; 
Farrokh Dehdashti, MD; 
Joanne Mortimer, MD*; 
Barry Siegel, MD; 
Stephanie Jonson, MS; 
Michael Welch, PhD, "PET 
assessment of response to 
tamoxifen therapy in 
patients with metastatic 
breast cancer." *Washington 
University, St. Louis, Mis- 
souri. 
Fidelma Flanagan, MD; 
Farrokh Dehdashti, MD: 
Barry Siegel, MD: Diana 
Trask, RN; Sudhir Sundare- 
san, MD*; Alexander Patter- 
son, MD*; Joel Cooper, 
MD*,"Staging of esophageal 
cancer with FDG-PET." 
*Washington University, St. 
Louis, Missouri. 
Fidelma Flanagan, MD; 
Farrokh Dehdashti, MD; 
Olagunji Ogunbiyi, MD; 
Barry Siegel, MD; Diana 
Trask, RN; Elisa Birnbaum, 
MD*; James Fleshman, MD*; 
Ira Kodner, MD*, "The role 
of FDG-PET in advanced 
primary and recurrent col- 
orectal cancer." *Washing- 
ton University, St. Louis, 
Missouri. 
Robert Hancock, PhD*; 
Michael Welch, PhD; 
David Reichert, PhD, 
"Molecular mechanics inves- 
tigation of Tc(V) com- 
plexes." *IBC Advanced 
Technologies, American 
Fork, Utah. 
Pilar Herrero, MD*; Judy 
Hartman, research patient 
coordinator*; Robert Gro- 
pler, MD; Steven Bergmann, 
MD*, "Quantification of 
myocardial perfusion with 
PET using carbon-11 acetate 
and a compartmental model 
in human subjects." *Wash- 
ington University, St. Louis, 
Missouri. 
Teresa Jones-Wilson, 
PhD; Kim Deal, PhD; Deb- 
orah McCarthy, PhD; 
David Reichert, PhD; Car- 
olyn Anderson, PhD; 
Michael Welch, PhD, "The 
effect of charge on the reten- 
tion of Copper-64 radiophar- 
maceuticals in the clearance 
organs." 
Hans Lee, MD*; Hiie Gussak, 
ultrasound technician*; 
Victor Davila-Roman, MD*; 
Deborah Delano, RN; 
Patricia Rubin, MD*; Robert 
Gropler, MD, "Contractile 
reserve is not dependent 
solely upon changes in 
myocardial blood flow." 
'"Washington University, 
St. Louis, Missouri. 
Deborah McCarthy, PhD; 
Ruth Shefer, PhD*; Robert 
Klinkowstein, PhD*; Laura 
Bass, PhD; William Margt- 
neau, cyclotron supervi- 
sor; Carolyn Anderson, 
PhD; Michael Welch, PhD 
"The efficient production oi 
high specific activity Coppe - 
64 using a biomedical 
cyclotron." *Newton Scien- 
tific Inc., Winchester, 
Massachusetts. 
Eyal Mishani, PhD; 
Michael Cristel, MS; Tim- 
othy McCarthy, PhD; 
Michael Welch, PhD, 
"Radiosynthesis binding 
affinity and biodistribution 
of 3-[F-18]fluoro-N-(3,a,3-tri- 
fluoro-m-toly)piperazine 
(FTFMPP), a Radioligand fc 
the Serotonin System." 
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Vijay Sharma, PhD; S. Wey, 
PhD*; Laura Bass, PhD; 
Carolyn Crankshaw, MS; 
Mark Green, PhD*; Michael 
Welch, PhD; David 
Piwnica-Worms, MD, PhD; 
"Monocationic N402 schiff- 
base phenolate complexes of 
Ga(III): novel PET imaging 
agents of the human mul- 
tidrug resistance (MDR1) P- 
glycoprotein." *Purdue 
University, West Lafayette, 
Indiana. 
ijay Sharma, PhD; Vallab- 
aneni Rao, PhD; David 
Reichert, PhD; Carolyn 
Crankshaw, MS; Michael 
Welch, PhD; David 
Piwnica-Worms, MD, PhD, 
"Effects of the central coor- 
dination metal on recogni- 
tion of ethylenediamine- 
N-N'-Bis[Propyl (R-Benzylim- 
ino)] metal (III) cations by 
the multidrug resistance 
(MDR1) P-glycoprotein." 
Jerold Wallis, MD; Tom 
Miller, MD, PhD; Mihelle 
Miller,* James Hamill, PhD**, 
"Rapid 3-D projection in iter- 
ative reconstruction using 
gaussian diffusion." *sum- 
mer student **Siemens Med- 
ical Systems, Hoffman 
Estates, Illinois. 
Samuel Wang, MD; Keith 
Fischer, MD; Richard 
Slone, MD; David Gierada, 
MD; Roger Yusen, MD*; Joel 
Cooper, MD*, "Ventilation 
perfusion scintigraphy in the 
evaluation of patients for 
lung volume reduction 
surgery." * Washington Uni- 
versity School of Medicine, 
St. Louis, Missouri. 
Jian Zhang, MS; Ming Xu, 
MS; Elizabeth Sherman, 
BA; Carmen Dence, MS; 
Timothy McCarthy, PhD; 
Michael Welch, PhD, " In 
vivo evaluation and PET 
study of a C-ll labeled neu- 
ronal nitric oxide synthase 




Tom Miller, MD, PhD, 
moderator, "Instrumentation 
and data analysis: image 
generation and analysis." 
Laura Bass, PhD; James 
Duncan, MD, PhD; Mary 
Stephenson, medical 
research technician; 
Michael Cristel, MS; Car- 
olyn Anderson, PhD, "In 
vivo metabolism of IN-111- 
DTPA-Octreotide." 
Carolyn Cranskshaw, MS; 
David Piwnica-Worms, 
MD, PhD, "TC-99m-SES- 
TAMIBI may be a transport 
substrate of the human mul- 
tidrug resistance-associated 
protein (MRP)." 
James Duncan, MD, PhD; 
Mary Stephenson, medical 
research technician; Car- 
olyn Anderson, PhD; Her- 
man Wu, medical student*, 
"IN-111-DTPA octreotide and 
other polypeptides are deliv- 
ered to lysosomes in the 
liver, kidneys, and target tis- 
sues." *Washington Univer- 
sity, St. Louis, Missouri. 
Pilar Herrero, MD*; Robert 
Gropler, MD; Mark Shelton, 
MD*; Steven Bergmann, MD, 
PhD*, "Use of compartmental 
models of Carbon-11 acetate 
to measure myocardial oxy- 
gen consumption: validation 
in human subjects." ♦Wash- 
ington University, St. Louis, 
Missouri. 
John Ollinger, DSc*; William 
Powers, MD; Lennis Lich, 
technical supervisor, 
"Shielding to reject scatter 
from outside the field-of-view 
in infant PET scans." ♦Wash- 
ington University, St. Louis, 
Missouri. 
Patricia Rubin, MD*; Debo- 
rah Delano, RN; Jason 
Rogers, MD*; Robert Gro- 
pler, MD, "Cardiac PET with 
C-ll acetate identifies 
patients referred for cardiac 
transplant who benefit from 
high-risk coronary bypass 
surgery." *Washington Uni- 
versity, St. Louis, Missouri. 
Jerold Wallis, MD; Tom 
Miller, MD, PhD, "Use of 
iterative methods in recon- 
struction of 180° data." 
Residents, trainees, and fellows (or 1995-1996 were (front row, left to right) Doctors Pamela Woodard; Rachel Gordon; Christine Menias; Myeong Yoon; Michele Semin; 
Neda Yagan; Gilbert Jost, chief. Division of Diagnostic Radiology; Donald Heck; Eric Weidman; Ronald Evens, director of the Institute; Dennis Balfe, director of the Diagnostic 
Radiology Program; Farrel VanWagenen; Thomas Vaughan; Mary Alderman; Isabel Soroeta; Sharon Schubach; Debra Lau; (second row) Michael Roarke; Samuel Wang; 
lawrence Kaskowitz; John Felker; Sanjeev Bhalla; Joshua Shimony; Peter Salazar; Dallas Peck; Mitchell Miller; Gavin Slethaug; Perry Pickhardt; Michael Boerner; James Mil- 
burn; Gregg Schubach; Sean Pierce; John Carico; Sean Muldowney; (third row) Felix Song; David Hillier; Jonathon Gurney; David Kim; Scott Kaltman; Kim Baker; Stephanie 
Hiskes; Kevin Berger; David Youmans; Sandy Ruhs; Kraig Kirkpatrick; Gregory Cizek; Anthony Zelazny; Donald Frei; (back row) George Brown; Kurt Simpson; Anthony Foti; 
Jahn Butman; Richard Edelstein; Eric Maiden; Jeffrey Friedland; Steven Winn; Matthew Fleishman; Andrew Fisher; Rory Satterfield; Robert McKinstry; Daniel Hassell; John 
Healy; Paul Guillerman; Robert Vogler; Glenn Hammer; Kenneth Ford; Michael Naylor; Ty Bae; Ken Schreibman. 
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IN MEMORIAM 
Michel M. Ter-Pogossian, PhD, an internationally known 
pioneer in the use of cyclotron-produced radionuclides 
in biomedical research, died suddenly of a heart attack on 
June 19, 1996, while visiting in Paris. He was emeritus pro- 
fessor of radiology at Washington University's Mallinckrodt 
Institute of Radiology. While the scientific world has lost an 
innovatve researcher who fostered collaboration among sci- 
entists and clinicians from various disciplines in order to 
achieve improved medical imaging, we at Mallinckrodt 
Institute have lost a dear friend and colleague. 
Born on April 21,1925, in 
Berlin, Michel Ter-Pogossian 
was the only child of Armen- 
ian parents who had settled 
in Germany after escaping 
ethnic persecution in their 
homeland following World 
War I. The family moved to 
France when Michel was a 
young child. His fascination 
with science began as a 
youngster and was fueled by 
experiments involving his 
toy physics and chemistry 
kits. He later earned 
degrees in science from the 
University of Paris and from 
the Institute of Radium in 
1943 and 1946, respectively. 
It was in 1946 that Ter- 
Pogossian came to the 
United States to further his 
education, an outgrowth of 
his father's concern about 
young Michel's involvement 
with the war resistance 
efforts in France. 
Ter-Pogossian was 
drawn to Washington Uni- 
versity in large part by the 
reputation of Arthur Holly 
Compton, a physicist and a 
Nobel laureate, who was the 
university's chancellor. In 
1946, while studying for his 
degree, Ter-Pogossian 
worked in the Department of 
Physics as a research assis- 
tant. He received a master's 
degree in 1948 and a doc- 
toral degree in nuclear 
physics in 1950. He joined 
the faculty of Mallinckrodt 
Institute in 1950 and was 
appointed as professor of 
radiation sciences in 1961. 
He also held a joint appoint- 
ment as professor of bio- 
physics in physiology. In 
1973, he was named head of 
Mallinckrodt Institute's Divi- 
sion of Radiation Sciences, 
but the self-professed 
"research junkie" missed 
devoting his full time to lab- 
oratory work. In 1990, he 
stepped down from his 
administrative duties to 
return to his first love: 
research. 
Among his many 
accomplishments, Michel 
Ter-Pogossian will foremost 
be remembered as the 
"father of PET." In the early 
1970s, he led a collaborative 
research team of physical 
scientists, chemists, and 
physicians who developed 
the concept of positron 
emission tomography (PET). 
A major medical contribu- 
tion, PET displays actual 
metabolic activity within dif- 
ferent regions of organs and 
tissues, thereby extending 
scientists' and physicians' 
understanding of basic bio- 
logical processes and pro- 
viding a basis for the 
improved diagnosis of dis- 
eases. He played a major 
role in developing the con- 
cept of short-lived isotopes 
and in designing and con- 
structing the first PET scan- 
ner as well as the first 
multislice and the first time- 
of-flight PET scanners. 
During a career that 
spanned more than four 
decades, he earned numer- 
ous accolades for his 
achievements in nuclear sci- 
ence, including France's 
Gold Medal Award of the 
Societe Francaise de 
Medecine Nucleaire et de 
Biophysique, Canada's pres- 
tigious Gairdner Award, St. 
Louis' Peter H. Raven Life- 
time Award of the Academy 
of Sciences, as well as the 
Society of Nuclear Medi- 
cine's Georg Charles de 
Hevesy Nuclear Medicine 
Pioneer Award and the Paul 
C. Aebersold Award. Ter- 
Pogossian was a member of 
many professional societies. 
He was elected in 1987 to 
the Institute of Medicine and 
served on the editorial 
boards of major scientific 
journals, including the 
American Journal of 
Roentgenology, the Journal 
of Nuclear Medicine, and 
the Journal de Biophysiqve 
& Medecine Nucleaire. 
Dr. Ter-Pogossian was a 
prolific author, with more 
than 250 papers and book 
chapters to his credit, and 
was a charter member of t le 
American Nuclear Society 
and a fellow of the Americ in 
Physical Society. In addi- 
tion, he was a past trustee if 
the Academy of Sciences o 
St. Louis and served as an 
advisor for several Depart- 
ment of Energy and Nation il 
Institutes of Health 
committees. 
' 
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^JEWISH »0; 
JUNE 1,1996 
1 Chancellor Mark Wrighton, Dr. Todd 
Wasserman, and Christine Bowman, a former 
patient of Dr. Wasserman's. 
2 Quentin Ringenberg travelled from Naples, 
Florida, to attend the celebration. 
3 Mr. and Mrs. Harold Gilling 
4 Norman Nachman, cancer-free for 22 years. 
5 The Cancer Infomation Center was one of the 
stops on the guided tours. 
6 Anne and Sam Flora, both cancer survivors, 
with daughter Elizabeth. 
7 Bernadette Rondle (center, shown with family 
members) spoke about her successful fight 
against lymphoma. 
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